0000732026 TRIO-TECH INTERNATIONAL
false --06-30 Q3 2022 253 311 709 679 0 0 15,000,000 15,000,000
4,029,180 4,029,180 3,913,055 3,913,055 4 2,000 314 2 4,025 2 2 9
10 10 5 5 22 10 5 906 1.85 5.5 1.25 4,214 3,900 1.85 5.5 5.5 900 2
0 4 0 5 0 0 0 0 0 0 0 5 0 0 0 0 20 4 3 4 1 3 100% owned by
Trio-Tech International Pte. Ltd. Down payment for purchase of
investment properties included: Amounts of RMB5,000 or
approximately $773 as disclosed in Note 5, plus the interest
receivable on Long-term loan receivable of RMB1,250 or
approximately $193, and impairment on interest of RMB 906 or
approximately $140. The shop lots are to be delivered to TTCQ upon
completion of the construction of the shop lots in the Singapore
Themed Resort Project. The initial targeted date of completion was
in fiscal year 2017. Based on discussion with the developers, the
completion date is currently estimated to be December 31, 2022. The
delay was primarily due to the time needed by the developers to
work with various parties to inject sufficient funds into this
project, especially during the COVID-19 pandemic During the fourth
quarter of 2021, The Company accrued an impairment charge of $1,580
related to the doubtful recovery of the down payment on shop lots
in the Singapore Theme Resort Project in Chongging, China, which
the impairment loss translated based on the exchange rate used in
the fiscal year 2021. The Company accounted for this non-cash
impairment charge because of increased uncertainties regarding the
project’s viability given the developer’s weakening financial
condition as well as uncertainties arising from the negative
real-estate environment in China, implementation of control
measures on real-estate lending and its relevant government
policies, together with effects of the ongoing pandemic. In fiscal
year 2011, the Company signed a Joint Venture agreement
(“agreement”) with Jia Sheng Property Development Co. Ltd.
(“Developer”) to form a new company, Jun Zhou Co., Limited (“Joint
Venture” or “Jun Zhou”) to joint develop the “Singapore Themed
Park” project (the “project”), where the Company paid RMB10 million
for the 10% investment in the joint venture. The Developer paid
Company a management fee of RMB5 million in cash upon signing of
the agreement with a remaining fee of RMB5 million payable upon
fulfillment of certain conditions in accordance with the agreement.
The Company further reduced its investment by RMB137, or
approximately $22 towards the losses from operations incurred by
the joint venture. 19 In fiscal year 2014, the Company disposed its
entire 10% interest in the joint venture. The Company recognized
the disposal of its 10% investment in Jun Zhou based on the
recorded net book value of RMB5 million, or equivalent to $803,
from net considerations paid, in accordance with US GAAP under ASC
Topic 845 Non-monetary Consideration, and it's presented under
“Other Assets” as noncurrent assets to defer the recognition of the
gain on the disposal of the 10% interest in the joint venture
investment until such time that the consideration is paid, so that
the gain can be ascertained. 00007320262021-07-012022-03-31
xbrli:shares 00007320262022-05-01 thunderdome:item iso4217:USD
00007320262022-03-31 00007320262021-06-30 iso4217:USDxbrli:shares
0000732026trt:ManufacturingMember2022-01-012022-03-31
0000732026trt:ManufacturingMember2021-01-012021-03-31
0000732026trt:ManufacturingMember2021-07-012022-03-31
0000732026trt:ManufacturingMember2020-07-012021-03-31
0000732026trt:TestingServicesMember2022-01-012022-03-31
0000732026trt:TestingServicesMember2021-01-012021-03-31
0000732026trt:TestingServicesMember2021-07-012022-03-31
0000732026trt:TestingServicesMember2020-07-012021-03-31
0000732026trt:DistributionMember2022-01-012022-03-31
0000732026trt:DistributionMember2021-01-012021-03-31
0000732026trt:DistributionMember2021-07-012022-03-31
0000732026trt:DistributionMember2020-07-012021-03-31
0000732026trt:RealEstateSegmentMember2022-01-012022-03-31
0000732026trt:RealEstateSegmentMember2021-01-012021-03-31
0000732026trt:RealEstateSegmentMember2021-07-012022-03-31
0000732026trt:RealEstateSegmentMember2020-07-012021-03-31
00007320262022-01-012022-03-31 00007320262021-01-012021-03-31
00007320262020-07-012021-03-31
0000732026us-gaap:CommonStockMember2021-06-30
0000732026us-gaap:AdditionalPaidInCapitalMember2021-06-30
0000732026us-gaap:RetainedEarningsMember2021-06-30
0000732026us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-30
0000732026us-gaap:NoncontrollingInterestMember2021-06-30
0000732026us-gaap:CommonStockMember2021-07-012022-03-31
0000732026us-gaap:AdditionalPaidInCapitalMember2021-07-012022-03-31
0000732026us-gaap:RetainedEarningsMember2021-07-012022-03-31
0000732026us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012022-03-31
0000732026us-gaap:NoncontrollingInterestMember2021-07-012022-03-31
0000732026us-gaap:CommonStockMember2022-03-31
0000732026us-gaap:AdditionalPaidInCapitalMember2022-03-31
0000732026us-gaap:RetainedEarningsMember2022-03-31
0000732026us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-31
0000732026us-gaap:NoncontrollingInterestMember2022-03-31
0000732026us-gaap:CommonStockMember2020-06-30
0000732026us-gaap:AdditionalPaidInCapitalMember2020-06-30
0000732026us-gaap:RetainedEarningsMember2020-06-30
0000732026us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-30
0000732026us-gaap:NoncontrollingInterestMember2020-06-30
00007320262020-06-30
0000732026us-gaap:CommonStockMember2020-07-012021-03-31
0000732026us-gaap:AdditionalPaidInCapitalMember2020-07-012021-03-31
0000732026us-gaap:RetainedEarningsMember2020-07-012021-03-31
0000732026us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-012021-03-31
0000732026us-gaap:NoncontrollingInterestMember2020-07-012021-03-31
0000732026us-gaap:CommonStockMember2021-03-31
0000732026us-gaap:AdditionalPaidInCapitalMember2021-03-31
0000732026us-gaap:RetainedEarningsMember2021-03-31
0000732026us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-31
0000732026us-gaap:NoncontrollingInterestMember2021-03-31
00007320262021-03-31 xbrli:pure
0000732026trt:ExpressTestCorporationDormantMember2022-03-31
0000732026trt:TrioTechReliabilityServicesDormantMember2022-03-31
0000732026trt:KtsIncorporatedDbaUniversalSystemsDormantMember2022-03-31
0000732026trt:EuropeanElectronicTestCentreDormantMember2022-03-31
0000732026trt:TrioTechInternationalPteLtdMember2022-03-31
0000732026trt:UniversalFarEastPteLtdMember2022-03-31
0000732026trt:TriotechInternationalThailandCoLtdMember2022-03-31
0000732026trt:TriotechBangkokCoLtdMember2022-03-31
0000732026trt:TriotechMalaysiaSdnBhdMember2022-03-31
0000732026trt:TriotechKualaLumpurSdnBhdMember2022-03-31
0000732026trt:PrestalEnterpriseSdnBhdMember2022-03-31
0000732026trt:TrioTechSipCoLtdMember2022-03-31
0000732026trt:TriotechChongqingCoLtdMember2022-03-31
0000732026trt:ShiInternationalPteLtdDormantMember2022-03-31
0000732026trt:PtShiIndonesiaDormantMember2022-03-31
0000732026trt:TriotechTianjinCoLtdMember2022-03-31
0000732026trt:TriotechJiangsuCoLtdMember2022-03-31
0000732026trt:TriotechTianjinCoLtdMember2022-03-31 utr:D
0000732026srt:MinimumMember2021-07-012022-03-31
0000732026srt:MaximumMember2021-07-012022-03-31
0000732026srt:SubsidiariesMember2022-03-31
0000732026srt:SubsidiariesMember2021-06-30
00007320262020-07-012021-06-30 iso4217:CNY utr:Y
0000732026us-gaap:RealEstateMember2021-07-012022-03-31
0000732026trt:MaoYeMember2022-03-31
0000732026trt:JiangHuaiMember2022-03-31
0000732026trt:FuliMember2022-03-31
0000732026us-gaap:RealEstateMember2020-07-012021-06-30
0000732026trt:MaoYeMember2021-06-30
0000732026trt:JiangHuaiMember2021-06-30
0000732026trt:FuliMember2021-06-30
0000732026trt:MaoYeMember2008-03-31
0000732026trt:MaoYeMember2021-07-012022-03-31
0000732026trt:MaoYeMember2021-01-012021-03-31
0000732026trt:MaoYeMember2020-07-012021-03-31
0000732026trt:MaoYeMember2022-01-012022-03-31
0000732026trt:JiangHuaiMember2009-07-012010-06-30
0000732026trt:JiangHuaiMember2022-01-012022-03-31
0000732026trt:JiangHuaiMember2021-07-012022-03-31
0000732026trt:JiangHuaiMember2021-01-012021-03-31
0000732026trt:JiangHuaiMember2020-07-012021-03-31
0000732026trt:TTCQMember2010-03-31 utr:acre
0000732026trt:TTCQMember2021-05-21 utr:sqm
0000732026trt:TTCQMember2021-05-212022-03-31 utr:sqft
0000732026trt:TTCQMember2020-10-31
0000732026trt:TTCQMember2019-11-012020-10-31
0000732026trt:TTCQMember2020-11-012021-04-30
0000732026trt:FuliMember2022-01-012022-03-31
0000732026trt:FuliMember2021-07-012022-03-31
0000732026trt:FuliMember2021-01-012021-03-31
0000732026trt:FuliMember2020-07-012021-03-31
0000732026country:CN2022-01-012022-03-31
0000732026country:CN2021-07-012022-03-31
0000732026country:CN2021-01-012021-03-31
0000732026country:CN2020-07-012021-03-31 00007320262010-12-02
00007320262013-10-02 00007320262021-04-012021-06-30
0000732026trt:TrioTechInternationalPteLtdMembersrt:MinimumMember2021-07-012022-03-31
0000732026trt:TrioTechInternationalPteLtdMembersrt:MaximumMember2021-07-012022-03-31
0000732026trt:TrioTechInternationalPteLtdMembertrt:SIBORRateMember2022-03-31
0000732026trt:TrioTechInternationalPteLtdMemberus-gaap:LondonInterbankOfferedRateLIBORMember2022-03-31
0000732026trt:TrioTechInternationalPteLtdMember2022-03-31
0000732026trt:UniversalFarEastPteLtdMember2021-07-012022-03-31
0000732026trt:UniversalFarEastPteLtdMembersrt:MinimumMember2021-07-012022-03-31
0000732026trt:UniversalFarEastPteLtdMembersrt:MaximumMember2021-07-012022-03-31
0000732026trt:UniversalFarEastPteLtdMember2022-03-31
0000732026trt:TrioTechInternationalPteLtdMember2021-07-012022-03-31
0000732026trt:TriotechMalaysiaSdnBhdMember2022-03-31
0000732026trt:TrioTechInternationalPteLtdMember2021-06-30
0000732026trt:UniversalFarEastPteLtdMember2021-06-30
0000732026trt:TriotechMalaysiaSdnBhdMember2021-06-30
0000732026trt:NotesPayableToBanks1Member2022-03-31
0000732026trt:NotesPayableToBanks1Member2021-06-30
0000732026trt:NotesPayableToBanks2Member2022-03-31
0000732026trt:NotesPayableToBanks2Member2021-06-30
0000732026trt:NotesPayableToBank3Member2022-03-31
0000732026trt:NotesPayableToBank3Member2021-06-30
0000732026country:MY2022-03-31 0000732026country:MY2021-06-30
0000732026us-gaap:IntersegmentEliminationMember2022-01-012022-03-31
0000732026us-gaap:IntersegmentEliminationMember2021-01-012021-03-31
0000732026trt:ManufacturingMember2022-03-31
0000732026trt:ManufacturingMember2021-03-31
0000732026trt:TestingServicesMember2022-03-31
0000732026trt:TestingServicesMember2021-03-31
0000732026trt:DistributionMember2022-03-31
0000732026trt:DistributionMember2021-03-31
0000732026trt:RealEstateSegmentMember2022-03-31
0000732026trt:RealEstateSegmentMember2021-03-31
0000732026trt:CorporateAndUnallocatedMember2021-07-012022-03-31
0000732026trt:CorporateAndUnallocatedMember2022-03-31
0000732026trt:CorporateAndUnallocatedMember2020-07-012021-03-31
0000732026trt:CorporateAndUnallocatedMember2021-03-31
0000732026trt:CorporateAndUnallocatedMember2022-01-012022-03-31
0000732026trt:CorporateAndUnallocatedMember2021-01-012021-03-31
0000732026us-gaap:OtherNonoperatingIncomeExpenseMember2022-01-012022-03-31
0000732026us-gaap:OtherNonoperatingIncomeExpenseMember2021-07-012022-03-31
0000732026us-gaap:OtherNonoperatingIncomeExpenseMember2021-01-012021-03-31
0000732026us-gaap:OtherNonoperatingIncomeExpenseMember2020-07-012021-03-31
0000732026srt:MinimumMember2022-03-31
0000732026srt:MaximumMember2022-03-31
0000732026us-gaap:EmployeeStockOptionMember2021-07-012022-03-31
0000732026srt:MinimumMember2021-03-31
0000732026srt:MaximumMember2021-03-31
00007320262021-03-012021-03-31
0000732026trt:EmployeeStockOptionPlan2007Member2007-09-242007-09-24
0000732026trt:DirectorPlan2007Member2017-09-242017-09-24
0000732026srt:MinimumMember2020-07-012021-03-31
0000732026srt:MaximumMember2020-07-012021-03-31
0000732026trt:EmployeeStockOptionPlan2017Membersrt:MaximumMember2021-07-012022-03-31
0000732026trt:EmployeeStockOptionPlan2017Membersrt:MinimumMember2021-07-012022-03-31
0000732026trt:EmployeeStockOptionPlan2017Membersrt:MaximumMember2022-01-012022-03-31
0000732026trt:EmployeeStockOptionPlan2017Member2021-07-012022-03-31
0000732026trt:EmployeeStockOptionPlan2017Memberus-gaap:ShareBasedCompensationAwardTrancheOneMember2021-07-012022-03-31
0000732026trt:EmployeeStockOptionPlan2017Member2022-01-012022-03-31
0000732026trt:EmployeeStockOptionPlan2017Member2021-01-012021-03-31
0000732026trt:EmployeeStockOptionPlan2017Member2020-07-012021-03-31
0000732026trt:EmployeeStockOptionPlan2017Member2022-03-31
0000732026trt:EmployeeStockOptionPlan2017Member2021-03-31
0000732026trt:EmployeeStockOptionPlan2017Member2021-06-30
0000732026trt:EmployeeStockOptionPlan2017Member2020-07-012021-06-30
0000732026trt:EmployeeStockOptionPlan2017Member2020-06-30
0000732026trt:EmployeeStockOptionPlan2017Member2019-07-012020-06-30
0000732026trt:EmployeeStockOptionPlan2007Member2021-07-012022-03-31
0000732026trt:UnvestedStockOptionMembertrt:DirectorPlan2017Member2020-07-012021-03-31
0000732026trt:DirectorPlan2007Member2020-07-012021-03-31
0000732026trt:EmployeeStockOptionPlan2007Member2021-03-012021-03-31
0000732026trt:EmployeeStockOptionPlan2007Member2020-07-012021-03-31
0000732026trt:EmployeeStockOptionPlan2007Member2021-03-31
0000732026trt:EmployeeStockOptionPlan2007Member2021-06-30
0000732026trt:EmployeeStockOptionPlan2007Member2020-07-012021-06-30
0000732026trt:EmployeeStockOptionPlan2007Member2020-06-30
0000732026trt:EmployeeStockOptionPlan2007Member2019-07-012020-06-30
0000732026trt:DirectorPlan2017Member2020-09-012020-09-30
0000732026trt:DirectorPlan2017Member2020-12-012020-12-31
0000732026trt:DirectorPlan2017Member2022-01-012022-03-31
0000732026trt:DirectorPlan2017Member2021-07-012022-03-31
0000732026trt:DirectorPlan2017Member2021-01-012021-03-31
0000732026trt:DirectorPlan2017Member2020-07-012021-03-31
0000732026trt:UnvestedStockOptionMembertrt:DirectorPlan2017Member2021-07-012022-03-31
0000732026trt:DirectorPlan2017Member2022-03-31
0000732026trt:DirectorPlan2017Member2021-03-31
0000732026trt:DirectorPlan2017Member2021-06-30
0000732026trt:DirectorPlan2017Member2020-07-012021-06-30
0000732026trt:DirectorPlan2017Member2020-06-30
0000732026trt:DirectorPlan2017Member2019-07-012020-06-30
0000732026trt:DirectorPlan2007Member2021-07-012022-03-31
0000732026trt:DirectorPlan2007Member2021-03-31
0000732026trt:DirectorPlan2007Member2022-03-31
0000732026trt:DirectorPlan2007Member2021-06-30
0000732026trt:DirectorPlan2007Member2020-07-012021-06-30
0000732026trt:DirectorPlan2007Member2020-06-30
0000732026trt:DirectorPlan2007Member2019-07-012020-06-30 utr:M
0000732026us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembertrt:CustomerAMember2021-07-012022-03-31
0000732026us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembertrt:CustomerAMember2020-07-012021-03-31
0000732026us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembertrt:CustomerBMember2021-07-012022-03-31
0000732026us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembertrt:CustomerBMember2020-07-012021-03-31
0000732026us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembertrt:CustomerAMember2021-07-012022-03-31
0000732026us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembertrt:CustomerAMember2020-07-012021-03-31
0000732026us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembertrt:CustomerBMember2021-07-012022-03-31
0000732026us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembertrt:CustomerBMember2020-07-012021-03-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended March 31, 2022
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the Transition Period from ___ to ___
Commission File Number 1-14523
TRIO-TECH INTERNATIONAL
(Exact name of Registrant as specified in its Charter)
California
|
95-2086631
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
incorporation or organization)
|
Identification Number)
|
|
|
Block 1008 Toa Payoh North
|
|
Unit 03-09 Singapore
|
318996
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant's Telephone Number, Including Area
Code: (65) 6265 3300
Securities registered pursuant to Section 12(b) of the Act:
Title of each
class
|
Trading Symbol
|
Name of each exchange
On which
registered
|
Common Stock, no par value
|
TRT
|
NYSE American
|
Securities registered pursuant to Section 12(g) of the Act:
None
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted
electronically every Interactive Data File required to be submitted
pursuant to Rule 405 of Regulation S-T during the preceding 12
months (or for such shorter period that the registrant was required
to submit and post such
files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a nonaccelerated filer, a
smaller reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer”,
“smaller reporting company” and "emerging growth company" in Rule
12b2 of the Exchange Act. (Check one):
Large Accelerated Filer
|
☐
|
Accelerated Filer
|
☐
|
Non-Accelerated Filer
|
☐
|
Smaller reporting company
|
☒
|
|
|
Emerging growth company
|
☐
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act). Yes
☐ No ☒
As of May 1, 2022, there were 4,029,180 shares of the issuer’s
Common Stock, no par value, outstanding.
TRIO-TECH INTERNATIONAL
INDEX TO
CONDENSED CONSOLIDATED FINANCIAL INFORMATION, OTHER INFORMATION AND
SIGNATURE
|
|
Page
|
Part I.
|
Financial Information
|
|
|
|
|
Item 1.
|
Financial Statements
|
|
|
(a) Condensed Consolidated Balance Sheets
as of March 31, 2022 (Unaudited), and June 30, 2021
|
2 |
|
(b) Condensed Consolidated Statements of
Operations and Comprehensive Income for the Three and Nine Months
Ended March 31, 2022 (Unaudited), and March 31, 2021
(Unaudited)
|
2 |
|
(c) Condensed Consolidated Statements of
Shareholders’ Equity for the Nine Months Ended March 31, 2022
(Unaudited), and the March 31, 2021 (Unaudited)
|
5 |
|
(d) Condensed Consolidated Statements of
Cash Flows for the Nine Months Ended March 31, 2022 (Unaudited),
and March 31, 2021 (Unaudited)
|
6 |
|
(e) Notes to Condensed Consolidated
Financial Statements (Unaudited)
|
7 |
Item 2.
|
Management’s Discussion and Analysis of
Financial Condition and Results of Operations
|
34 |
Item 3.
|
Quantitative and Qualitative Disclosures
about Market Risk
|
52 |
Item 4.
|
Controls and Procedures
|
52 |
|
|
|
Part II.
|
Other Information
|
|
|
|
|
Item 1.
|
Legal Proceedings
|
53 |
Item 1A.
|
Risk Factors
|
53 |
Item 2.
|
Unregistered Sales of Equity Securities and
Use of Proceeds
|
53 |
Item 3.
|
Defaults upon Senior Securities
|
53 |
Item 4.
|
Mine Safety Disclosures
|
53 |
Item 5.
|
Other Information
|
53 |
Item 6.
|
Exhibits
|
53 |
|
|
|
Signatures
|
54 |
FORWARD-LOOKING
STATEMENTS
The discussions of Trio-Tech International’s (the “Company”)
business and activities set forth in this Form 10-Q and in other
past and future reports and announcements by the Company may
contain forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended, and assumptions
regarding future activities and results of operations of the
Company. In light of the “safe harbor” provisions of the
Private Securities Litigation Reform Act of 1995, the following
factors, among others, could cause actual results to differ
materially from those reflected in any forward-looking statements
made by or on behalf of the Company: market acceptance of Company
products and services; changing business conditions or technologies
and volatility in the semiconductor industry, which could affect
demand for the Company’s products and services; the impact of
competition; problems with technology; product development
schedules; delivery schedules; changes in military or commercial
testing specifications which could affect the market for the
Company’s products and services; difficulties in profitably
integrating acquired businesses, if any, into the Company; risks
associated with conducting business internationally and especially
in Asia, including currency fluctuations and devaluation, currency
restrictions, local laws and restrictions and possible social,
political and economic instability; changes in U.S. and global
financial and equity markets, including market disruptions and
significant interest rate fluctuations; ongoing public health
issues related to the COVID-19 pandemic; the trade tension between
U.S. and China; other economic, financial and regulatory factors
beyond the Company’s control and uncertainties relating to our
ability to operate our business in China; uncertainties regarding
the enforcement of laws and the fact that rules and regulation in
China can change quickly with little advance notice, along with the
risk that the Chinese government may intervene or influence our
operation at any time, or may exert more control over offerings
conducted overseas and/or foreign investment in China-based issuers
could result in a material change in our operations, financial
performance and/or the value of our common stock or impair our
ability to raise money. Other than statements of historical fact,
all statements made in this Quarterly Report are forward-looking,
including, but not limited to, statements regarding industry
prospects, future results of operations or financial position, and
statements of our intent, belief and current expectations about our
strategic direction, prospective and future financial results and
condition. In some cases, you can identify forward-looking
statements by the use of terminology such as “may,” “will,”
“expects,” “plans,” “anticipates,” “estimates,” “potential,”
“believes,” “can impact,” “continue,” or the negative thereof or
other comparable terminology. Forward-looking statements
involve risks and uncertainties that are inherently difficult to
predict, which could cause actual outcomes and results to differ
materially from our expectations, forecasts and assumptions.
Unless otherwise required by law, we undertake no obligation to
update forward-looking statements to reflect subsequent events,
changed circumstances, or the occurrence of unanticipated events.
You are cautioned not to place undue reliance on such
forward-looking statements.
PART
I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
TRIO-TECH INTERNATIONAL AND SUBSIDIARIES
CONDENSED CONSOLIDATED
BALANCE SHEETS (IN THOUSANDS, EXCEPT NUMBER OF
SHARES)
|
|
March 31,
2022
|
|
|
June 30,
2021
|
|
|
|
(Unaudited)
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
CURRENT ASSETS:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
7,478 |
|
|
$ |
5,836 |
|
Short-term deposits
|
|
|
4,953 |
|
|
|
6,651 |
|
Trade accounts receivable, less allowance for doubtful accounts of
$253 and
$311,
respectively
|
|
|
10,585 |
|
|
|
8,293 |
|
Other receivables
|
|
|
735 |
|
|
|
325 |
|
Contract assets |
|
|
594 |
|
|
|
337 |
|
Inventories, less provision for obsolete inventories of
$709 and
$679,
respectively
|
|
|
2,272 |
|
|
|
2,080 |
|
Prepaid expenses and other current assets
|
|
|
732 |
|
|
|
418 |
|
Financed sales receivable
|
|
|
21 |
|
|
|
19 |
|
Total current assets
|
|
|
27,370 |
|
|
|
23,959 |
|
NONCURRENT ASSETS:
|
|
|
|
|
|
|
|
|
Deferred tax assets
|
|
|
189 |
|
|
|
217 |
|
Investment properties, net
|
|
|
636 |
|
|
|
681 |
|
Property, plant and equipment, net
|
|
|
9,107 |
|
|
|
9,531 |
|
Operating lease right-of-use assets
|
|
|
2,602 |
|
|
|
1,876 |
|
Other assets
|
|
|
141 |
|
|
|
262 |
|
Restricted term deposits
|
|
|
1,735 |
|
|
|
1,741 |
|
Financed sales receivable
|
|
|
23 |
|
|
|
39 |
|
Total noncurrent assets
|
|
|
14,433 |
|
|
|
14,347 |
|
TOTAL ASSETS
|
|
$ |
41,803 |
|
|
$ |
38,306 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES:
|
|
|
|
|
|
|
|
|
Lines of credit
|
|
$ |
523 |
|
|
$ |
72 |
|
Accounts payable
|
|
|
2,220 |
|
|
|
3,702 |
|
Accrued expenses
|
|
|
3,870 |
|
|
|
2,690 |
|
Contract liabilities |
|
|
1,172 |
|
|
|
673 |
|
Income taxes payable
|
|
|
476 |
|
|
|
314 |
|
Current portion of bank loans payable
|
|
|
493 |
|
|
|
439 |
|
Current portion of finance leases
|
|
|
136 |
|
|
|
197 |
|
Current portion of operating leases
|
|
|
758 |
|
|
|
672 |
|
Total current liabilities
|
|
|
9,648 |
|
|
|
8,759 |
|
NONCURRENT LIABILITIES:
|
|
|
|
|
|
|
|
|
Bank loans payable, net of current portion
|
|
|
1,470 |
|
|
|
1,621 |
|
Finance leases, net of current portion
|
|
|
152 |
|
|
|
253 |
|
Operating leases, net of current portion
|
|
|
1,844 |
|
|
|
1,204 |
|
Income taxes payable, net of current portion
|
|
|
281 |
|
|
|
385 |
|
Other noncurrent liabilities
|
|
|
31 |
|
|
|
31 |
|
Total noncurrent liabilities
|
|
|
3,778 |
|
|
|
3,494 |
|
TOTAL LIABILITIES
|
|
$ |
13,426 |
|
|
$ |
12,253 |
|
|
|
|
|
|
|
|
|
|
EQUITY
|
|
|
|
|
|
|
|
|
TRIO-TECH INTERNATIONAL’S SHAREHOLDERS’ EQUITY:
|
|
|
|
|
|
|
|
|
Common stock, no par value, 15,000,000 shares
authorized; 4,029,180 shares issued
outstanding as at March 31, 2022 and 3,913,055 shares as at
June 30, 2021, respectively
|
|
$ |
12,607 |
|
|
$ |
12,178 |
|
Paid-in capital
|
|
|
4,692 |
|
|
|
4,233 |
|
Accumulated retained earnings
|
|
|
8,429 |
|
|
|
6,824 |
|
Accumulated other comprehensive income-translation adjustments
|
|
|
2,392 |
|
|
|
2,399 |
|
Total Trio-Tech International shareholders’
equity
|
|
|
28,120 |
|
|
|
25,634 |
|
Noncontrolling interest
|
|
|
257 |
|
|
|
419 |
|
TOTAL EQUITY
|
|
$ |
28,377 |
|
|
$ |
26,053 |
|
TOTAL LIABILITIES AND EQUITY
|
|
$ |
41,803 |
|
|
$ |
38,306 |
|
See notes to condensed consolidated financial statements
TRIO-TECH INTERNATIONAL AND
SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE INCOME / (LOSS)
UNAUDITED (IN THOUSANDS, EXCEPT EARNINGS PER SHARE)
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
Mar. 31,
|
|
|
Mar. 31,
|
|
|
Mar. 31,
|
|
|
Mar. 31,
|
|
|
|
2022
|
|
|
2021
|
|
|
2022
|
|
|
2021
|
|
Revenue
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Manufacturing
|
|
$ |
3,097 |
|
|
$ |
3,130 |
|
|
$ |
10,187 |
|
|
$ |
9,324 |
|
Testing services
|
|
|
4,417 |
|
|
|
3,504 |
|
|
|
13,983 |
|
|
|
10,018 |
|
Distribution
|
|
|
3,620 |
|
|
|
1,467 |
|
|
|
8,038 |
|
|
|
3,790 |
|
Real estate
|
|
|
4 |
|
|
|
11 |
|
|
|
23 |
|
|
|
22 |
|
|
|
|
11,138 |
|
|
|
8,112 |
|
|
|
32,231 |
|
|
|
23,154 |
|
Cost of Sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of manufactured products sold
|
|
|
2,530 |
|
|
|
2,148 |
|
|
|
7,838 |
|
|
|
6,855 |
|
Cost of testing services rendered
|
|
|
3,169 |
|
|
|
2,651 |
|
|
|
9,141 |
|
|
|
7,651 |
|
Cost of distribution
|
|
|
2,945 |
|
|
|
1,234 |
|
|
|
6,651 |
|
|
|
3,142 |
|
Cost of real estate
|
|
|
20 |
|
|
|
19 |
|
|
|
58 |
|
|
|
58 |
|
|
|
|
8,664 |
|
|
|
6,052 |
|
|
|
23,688 |
|
|
|
17,706 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Margin
|
|
|
2,474 |
|
|
|
2,060 |
|
|
|
8,543 |
|
|
|
5,448 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative
|
|
|
2,378 |
|
|
|
1,923 |
|
|
|
6,305 |
|
|
|
5,245 |
|
Selling
|
|
|
146 |
|
|
|
123 |
|
|
|
449 |
|
|
|
356 |
|
Research and development
|
|
|
80 |
|
|
|
79 |
|
|
|
293 |
|
|
|
277 |
|
Gain on disposal of property, plant and equipment
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(1 |
)
|
Total operating expenses
|
|
|
2,604 |
|
|
|
2,125 |
|
|
|
7,047 |
|
|
|
5,877 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss)/ Income from Operations
|
|
|
(130 |
)
|
|
|
(65 |
)
|
|
|
1,496 |
|
|
|
(429 |
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Income / (Expenses)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expenses
|
|
|
(31 |
)
|
|
|
(25 |
)
|
|
|
(87 |
)
|
|
|
(96 |
)
|
Other income, net
|
|
|
127 |
|
|
|
273 |
|
|
|
669 |
|
|
|
627 |
|
Total other income
|
|
|
96 |
|
|
|
248 |
|
|
|
582 |
|
|
|
531 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) / Income from Continuing Operations before Income
Taxes
|
|
|
(34 |
) |
|
|
183 |
|
|
|
2,078 |
|
|
|
102 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Tax Expenses
|
|
|
(170 |
)
|
|
|
(118 |
) |
|
|
(503 |
)
|
|
|
(125 |
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) / Income from continuing operations before non-controlling
interest, net of tax
|
|
|
(204 |
) |
|
|
65 |
|
|
|
1,575 |
|
|
|
(23 |
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discontinued Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income / (loss) from discontinued operations, net of tax
|
|
|
- |
|
|
|
1 |
|
|
|
5 |
|
|
|
(26 |
)
|
NET (LOSS) / INCOME
|
|
|
(204 |
) |
|
|
66 |
|
|
|
1,580 |
|
|
|
(49 |
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: net income / (loss) attributable to noncontrolling
interest
|
|
|
(37 |
) |
|
|
(112 |
)
|
|
|
(25 |
)
|
|
|
(454 |
)
|
Net (Loss) / Income Attributable to Trio-Tech International
Common Shareholders
|
|
$ |
(167 |
)
|
|
$ |
178 |
|
|
$ |
1,605 |
|
|
$ |
405 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts Attributable to Trio-Tech International Common
Shareholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) / Income from continuing operations, net of tax
|
|
|
(167 |
)
|
|
|
177 |
|
|
|
1,603 |
|
|
|
418 |
|
Income / (Loss) from discontinued operations, net of tax
|
|
|
- |
|
|
|
1 |
|
|
|
2 |
|
|
|
(13 |
)
|
Net (Loss) / Income Attributable to Trio-Tech International
Common Shareholders
|
|
$ |
(167 |
)
|
|
$ |
178 |
|
|
$ |
1,605 |
|
|
$ |
405 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic (Loss) / Earnings per Share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic (loss) / earnings per share from continuing operations
attributable to Trio-Tech International
|
|
$ |
(0.04 |
)
|
|
$ |
0.05 |
|
|
$ |
0.40 |
|
|
$ |
0.11 |
|
Basic earnings per share from discontinued operations attributable
to Trio-Tech International
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
Basic (Loss) / Earnings per Share from Net Income
Attributable to Trio-Tech International
|
|
$ |
(0.04 |
)
|
|
$ |
0.05 |
|
|
$ |
0.40 |
|
|
$ |
0.11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted (Loss) / Earnings per Share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted (loss) / earnings per share from continuing operations
attributable to Trio-Tech International
|
|
$ |
(0.04 |
)
|
|
$ |
0.04 |
|
|
$ |
0.38 |
|
|
$ |
0.10 |
|
Diluted earnings per share from discontinued operations
attributable to Trio-Tech International
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
Diluted (Loss) / Earnings per Share from Net Income
Attributable to Trio-Tech International
|
|
$ |
(0.04 |
)
|
|
$ |
0.04 |
|
|
$ |
0.38 |
|
|
$ |
0.10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
3,949 |
|
|
|
3,913 |
|
|
|
3,949 |
|
|
|
3,913 |
|
Dilutive effect of stock options
|
|
|
272 |
|
|
|
133 |
|
|
|
191 |
|
|
|
117 |
|
Number of shares used to compute earnings per share diluted
|
|
|
4,221 |
|
|
|
4,046 |
|
|
|
4,140 |
|
|
|
4,030 |
|
See notes to condensed consolidated financial statements.
TRIO-TECH INTERNATIONAL AND
SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME /
(LOSS)
UNAUDITED (IN THOUSANDS)
|
|
Three Months Ended
|
|
|
Nine
Months Ended |
|
|
|
Mar. 31,
|
|
|
Mar. 31,
|
|
|
Mar. 31,
|
|
|
Mar. 31, |
|
|
|
2022
|
|
|
2021
|
|
|
2022
|
|
|
2021 |
|
Comprehensive Income Attributable to Trio-Tech International
Common Shareholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) / income
|
|
$ |
(204 |
) |
|
$ |
66 |
|
|
$ |
1,580 |
|
|
$ |
(49 |
) |
Foreign currency translation, net of tax
|
|
|
16 |
|
|
|
(468 |
) |
|
|
(22 |
) |
|
|
1,115 |
|
Comprehensive (Loss) / Income
|
|
|
(188 |
) |
|
|
(402 |
) |
|
|
1,558 |
|
|
|
1,066 |
|
Less: comprehensive loss attributable to noncontrolling
interest
|
|
|
(46 |
) |
|
|
(136 |
) |
|
|
(40 |
) |
|
|
(455 |
) |
Comprehensive (Loss) / Income Attributable to Trio-Tech
International Common Shareholders
|
|
$ |
(142 |
) |
|
$ |
(266 |
) |
|
$ |
1,598 |
|
|
$ |
1,521 |
|
See notes to condensed consolidated financial statements.
TRIO-TECH INTERNATIONAL AND
SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS'
EQUITY
UNAUDITED (IN THOUSANDS)
Nine months ended March 31, 2022
|
|
Common
Stock
|
|
|
Paid-in
|
|
|
Accumulated Retained
|
|
|
Accumulated Other
Comprehensive
|
|
|
Non- controlling
|
|
|
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Earnings
|
|
|
Income
|
|
|
Interest
|
|
|
Total
|
|
|
|
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Balance at June 30, 2021
|
|
|
3,913 |
|
|
|
12,178 |
|
|
|
4,233 |
|
|
|
6,824 |
|
|
|
2,399 |
|
|
|
419 |
|
|
|
26,053 |
|
Stock option expenses
|
|
|
- |
|
|
|
- |
|
|
|
459 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
459 |
|
Net income / (loss)
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,605 |
|
|
|
- |
|
|
|
(25 |
)
|
|
|
1,580 |
|
Dividend declared by subsidiary
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(122 |
)
|
|
|
(122 |
)
|
Exercise of stock option
|
|
|
116 |
|
|
|
429 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
429 |
|
Translation adjustment
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(7 |
)
|
|
|
(15 |
)
|
|
|
(22 |
)
|
Balance at Mar. 31, 2022
|
|
|
4,029 |
|
|
|
12,607 |
|
|
|
4,692 |
|
|
|
8,429 |
|
|
|
2,392 |
|
|
|
257 |
|
|
|
28,377 |
|
Nine months ended March 31, 2021
|
|
Common
Stock
|
|
|
Paid-in
|
|
|
Accumulated Retained
|
|
|
Accumulated Other
Comprehensive
|
|
|
Non- controlling
|
|
|
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Earnings
|
|
|
Income
|
|
|
Interest
|
|
|
Total
|
|
|
|
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Balance at June 30, 2020
|
|
|
3,673 |
|
|
|
11,424 |
|
|
|
3,363 |
|
|
|
8,036 |
|
|
|
1,143 |
|
|
|
1,180 |
|
|
|
25,146 |
|
Stock option expenses
|
|
|
- |
|
|
|
- |
|
|
|
144 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
144 |
|
Net income / (loss)
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
405 |
|
|
|
- |
|
|
|
(454 |
)
|
|
|
(49 |
)
|
Dividend declared by subsidiary
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(189 |
)
|
|
|
(189 |
)
|
Exercise of stock option
|
|
|
240 |
|
|
|
754 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
754 |
|
Translation adjustment
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,116 |
|
|
|
(1 |
)
|
|
|
1,115 |
|
Balance at Mar. 31, 2021
|
|
|
3,913 |
|
|
|
12,178 |
|
|
|
3,507 |
|
|
|
8,441 |
|
|
|
2,259 |
|
|
|
536 |
|
|
|
26,921 |
|
See notes to condensed consolidated financial statements.
TRIO-TECH INTERNATIONAL AND
SUBSIDIARIES
CONDENSED CONSOLIDATED
STATEMENTS OF CASH FLOWS (IN THOUSANDS)
|
|
Nine Months Ended
|
|
|
|
Mar. 31,
|
|
|
Mar. 31,
|
|
|
|
2022
|
|
|
2021
|
|
|
|
(Unaudited)
|
|
|
(Unaudited)
|
|
Cash Flow from Operating Activities
|
|
|
|
|
|
|
|
|
Net income / (loss)
|
|
$ |
1,580 |
|
|
$ |
(49 |
) |
Adjustments to reconcile net income to net cash flow provided by
operating activities
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
2,263 |
|
|
|
2,224 |
|
Stock compensation
|
|
|
459 |
|
|
|
144 |
|
Addition / (reversal) of provision for obsolete inventories
|
|
|
25 |
|
|
|
(2 |
)
|
Bad debt recovery, net of allowance charged
|
|
|
(61 |
)
|
|
|
(15 |
)
|
Accrued interest expense, net (accrued interest income)
|
|
|
85 |
|
|
|
(18 |
)
|
Payment of interest portion of finance lease
|
|
|
(20 |
)
|
|
|
(32 |
)
|
Gain on sale of property, plant and equipment
|
|
|
- |
|
|
|
(1 |
)
|
Dividend income
|
|
|
- |
|
|
|
(32 |
)
|
Dividend received
|
|
|
- |
|
|
|
32 |
|
Reversal of income tax provision
|
|
|
(18 |
)
|
|
|
- |
|
Deferred tax benefit
|
|
|
(7 |
)
|
|
|
(70 |
)
|
Changes in operating assets and liabilities, net of acquisition
effects
|
|
|
|
|
|
|
|
|
Trade accounts receivable
|
|
|
(2,214 |
)
|
|
|
(1,013 |
)
|
Other receivables
|
|
|
(688 |
)
|
|
|
320 |
|
Other assets
|
|
|
134 |
|
|
|
(33 |
)
|
Inventories
|
|
|
(233 |
)
|
|
|
(624 |
)
|
Prepaid expenses and other current assets
|
|
|
(312 |
)
|
|
|
(76 |
)
|
Accounts payable and accrued expenses
|
|
|
242 |
|
|
|
754 |
|
Income taxes payable
|
|
|
145 |
|
|
|
(44 |
)
|
Operating lease liabilities
|
|
|
(801 |
)
|
|
|
(565 |
)
|
Net Cash Provided by Operating Activities
|
|
|
579 |
|
|
|
900 |
|
|
|
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
|
|
|
|
|
|
|
|
Proceeds from disposal of property, plant and equipment
|
|
|
|
|
|
|
- |
|
Proceeds from sale of asset held for sale
|
|
|
|
|
|
|
- |
|
Withdrawal of unrestricted deposit
|
|
|
3,761 |
|
|
|
1,166 |
|
Investment in unrestricted term deposits, net
|
|
|
(2,079 |
) |
|
|
(1,370 |
)
|
Additions to property, plant and equipment
|
|
|
(1,144 |
) |
|
|
(621 |
)
|
Net Cash Provided by/ (Used in) Investing Activities
|
|
|
538 |
|
|
|
(825 |
)
|
|
|
|
|
|
|
|
|
|
Cash Flow from Financing Activities
|
|
|
|
|
|
|
|
|
Payment on lines of credit
|
|
|
(1,025 |
) |
|
|
(174 |
)
|
Payment of bank loans
|
|
|
(322 |
) |
|
|
(296 |
)
|
Payment of principal portion of finance leases
|
|
|
(168 |
) |
|
|
(192 |
)
|
Dividends paid to noncontrolling interest
|
|
|
(122 |
) |
|
|
(189 |
)
|
Proceeds from bank loan
|
|
|
255 |
|
|
|
189 |
|
Proceeds from exercise stock options
|
|
|
429 |
|
|
|
754 |
|
Proceeds from lines of credit
|
|
|
1,463 |
|
|
|
187 |
|
Proceeds from principal of finance leases
|
|
|
- |
|
|
|
- |
|
Net Cash Provided by Financing Activities
|
|
|
510 |
|
|
|
279 |
|
|
|
|
|
|
|
|
|
|
Effect of Changes in Exchange Rate
|
|
|
9 |
|
|
|
753 |
|
|
|
|
|
|
|
|
|
|
Net Increase in Cash, Cash Equivalents, and Restricted
Cash
|
|
|
1,636 |
|
|
|
1,107 |
|
Cash, Cash Equivalents, and Restricted Cash at Beginning of
Period
|
|
|
7,577 |
|
|
|
5,810 |
|
Cash, Cash Equivalents, and Restricted Cash at end of
Period
|
|
$ |
9,213 |
|
|
$ |
6,917 |
|
|
|
|
|
|
|
|
|
|
Supplementary Information of Cash Flows
|
|
|
|
|
|
|
|
|
Cash paid during the period for:
|
|
|
|
|
|
|
|
|
Interest
|
|
$ |
84 |
|
|
$ |
69 |
|
Income taxes
|
|
$ |
342 |
|
|
$ |
203 |
|
|
|
|
|
|
|
|
|
|
Reconciliation of Cash, Cash Equivalents, and Restricted
Cash
|
|
|
|
|
|
|
|
|
Cash
|
|
|
7,478 |
|
|
|
5,178 |
|
Restricted Term-Deposits in Noncurrent Assets
|
|
|
1,735 |
|
|
|
1,739 |
|
Total Cash, Cash Equivalents, and Restricted Cash Shown in the
Statements of Cash Flows
|
|
$ |
9,213 |
|
|
$ |
6,917 |
|
See notes to condensed consolidated financial statements.
Amounts included in restricted deposits represent the amount of
cash pledged to secure loans payable or trade financing granted by
financial institutions and serve as collateral for public utility
agreements such as electricity and water. Restricted deposits are
classified as noncurrent assets as they relate to long-term
obligations and will become unrestricted only upon discharge of the
obligations.
TRIO-TECH INTERNATIONAL AND
SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(IN THOUSANDS, EXCEPT EARNINGS PER SHARE AND NUMBER OF
SHARES)
1. ORGANIZATION AND
BASIS OF PRESENTATION
Trio-Tech International (“the Company” or “TTI” hereafter) was
incorporated in fiscal year 1958
under the laws of the State of California. TTI provides third-party semiconductor testing and burn-in
services primarily through its laboratories in Southeast Asia. In
addition, TTI operates testing facilities in the United States. The
Company also designs, develops, manufactures and markets a broad
range of equipment and systems used in the manufacturing and
testing of semiconductor devices and electronic components. In the
third quarter of fiscal year
2022, TTI conducted business in
four business
segments: Manufacturing, Testing Services, Distribution and Real
Estate. TTI has subsidiaries in the U.S., Singapore, Malaysia,
Thailand, Indonesia, Ireland and China as follows:
|
Ownership
|
|
Location
|
Express Test Corporation (Dormant)
|
100%
|
|
Van Nuys, California
|
Trio-Tech Reliability Services (Dormant)
|
100%
|
|
Van Nuys, California
|
KTS Incorporated, dba Universal Systems (Dormant)
|
100%
|
|
Van Nuys, California
|
European Electronic Test Centre (Dormant)
|
100%
|
|
Dublin, Ireland
|
Trio-Tech International Pte. Ltd.
|
100%
|
|
Singapore
|
Universal (Far East) Pte. Ltd. *
|
100%
|
|
Singapore
|
Trio-Tech International (Thailand) Co. Ltd. *
|
100%
|
|
Bangkok, Thailand
|
Trio-Tech (Bangkok) Co. Ltd.
|
100%
|
|
Bangkok, Thailand
|
Trio-Tech (Malaysia) Sdn. Bhd.
(55% owned by Trio-Tech International Pte. Ltd.)
|
55%
|
|
Penang and Selangor, Malaysia
|
Trio-Tech (Kuala Lumpur) Sdn. Bhd.
(100% owned by Trio-Tech Malaysia Sdn. Bhd.)
|
55%
|
|
Selangor, Malaysia
|
Prestal Enterprise Sdn. Bhd.
(76% owned by Trio-Tech International Pte. Ltd.)
|
76%
|
|
Selangor, Malaysia
|
Trio-Tech (SIP) Co., Ltd. *
|
100%
|
|
Suzhou, China
|
Trio-Tech (Chongqing) Co. Ltd. *
|
100%
|
|
Chongqing, China
|
SHI International Pte. Ltd. (Dormant)
(55% owned by Trio-Tech International Pte. Ltd)
|
55%
|
|
Singapore
|
PT SHI Indonesia (Dormant)
(100% owned by SHI International Pte. Ltd.)
|
55%
|
|
Batam, Indonesia
|
Trio-Tech (Tianjin) Co., Ltd. *
|
100%
|
|
Tianjin, China
|
Trio-Tech (Jiangsu) Co., Ltd.
|
51%
|
|
Suzhou, China
|
* 100% owned by Trio-Tech International Pte. Ltd.
The accompanying unaudited condensed consolidated financial
statements have been prepared in accordance with United States
Generally Accepted Accounting Principles (“GAAP”) for interim
financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. All significant intercompany accounts and
transactions have been eliminated in consolidation. The unaudited
condensed consolidated financial statements are presented in U.S.
dollars. The accompanying condensed consolidated financial
statements do not include all the
information and footnotes required by GAAP for complete financial
statements. For further information, refer to the consolidated
financial statements and footnotes thereto included in the
Company's annual report for the fiscal year ended June 30, 2021. The Company’s operating
results are presented based on the translation of foreign
currencies using the respective quarter’s average exchange
rate.
Certain accounting matters that generally require consideration of
forecasted financial information were assessed regarding impacts
from the COVID-19 pandemic as of
March 31, 2022, and through the
Quarterly Report dated May 16, 2022
using reasonably available information as of those dates. Those
accounting matters assessed included, but were not limited to, allowance for doubtful
accounts, the carrying value of long-lived tangible assets and the
valuation allowances for tax assets. While the assessments resulted
in no material impacts to the
consolidated financial statements as of and for the quarter ended
March 31, 2022, the Company
believes the full impact of the pandemic remains uncertain and the
Company will continue to assess if ongoing developments related to
the pandemic may cause future
material impacts to our consolidated financial statements. As of
March 31, 2022, the Company had
cash and cash equivalents and short-term deposits totaling $12,431
and unused lines of credit of $5,158. We finance operations
primarily through our existing cash balances, cash collected from
operations, bank borrowings and capital lease financing. We believe
these sources are sufficient to fund our operations for the
foreseeable future. For further information, refer to the
consolidated financial statements and footnotes thereto included in
the Company's annual report for the fiscal year ended June 30, 2021.
Basis of Presentation
and Summary of Significant Accounting Policies
The Company’s core businesses — testing services, manufacturing and
distribution — operate in a volatile industry, whereby its average
selling prices and product costs are influenced by competitive
factors. These factors create pressures on sales, costs, earnings
and cash flows, which will impact liquidity.
All dollar amounts in the consolidated financial statements and in
the notes herein are presented in thousands of United States
dollars (US$’000) unless otherwise
designated.
Liquidity — The Company earned net income attributable to
common shareholders of $1,605 and earned net income attributable to
common shareholders of $405 for the nine months ended March 31, 2022, and March 31, 2021, respectively.
Foreign Currency Translation and Transactions — The U.S.
dollar is the functional currency of the U.S. parent company. The
Singapore dollar, the national currency of Singapore, is the
primary currency of the economic environment in which the
operations in Singapore are conducted. The Company also has
business entities in Malaysia, Thailand, China and Indonesia of
which the Malaysian ringgit (“RM”), Thai baht, Chinese renminbi
(“RMB”) and Indonesian rupiah, are the national currencies. The
Company uses the U.S. dollar for financial reporting purposes.
The Company translates assets and liabilities of its subsidiaries
outside the U.S. into U.S. dollars using the rate of exchange
prevailing at the period end, and the consolidated statements of
operations and comprehensive income or loss is translated at
average rates during the reporting period. Adjustments resulting
from the translation of the subsidiaries’ financial statements from
foreign currencies into U.S. dollars are recorded in shareholders'
equity as part of accumulated other comprehensive gain -
translation adjustments. Gains or losses resulting from
transactions denominated in currencies other than functional
currencies of the Company’s subsidiaries are reflected in income
for the reporting period.
Use of Estimates — The preparation of consolidated financial
statements in conformity with accounting principles generally
accepted in the United States of America requires management to
make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and
liabilities at the date of the consolidated financial statements
and the reported amounts of revenues and expenses during the
reporting period. Among the more significant estimates included in
these consolidated financial statements are the estimated allowance
for doubtful account receivables, reserve for obsolete inventory,
impairments, provision of income tax, stock options and the
deferred income asset allowance. Actual results could materially
differ from those estimates.
Revenue Recognition — The Company follows ASU No. 2014-09, ASC
Topic 606, Revenue from
Contracts with Customers (“ASC Topic 606”). This standard update outlines a single
comprehensive model for entities to use in accounting for revenue
arising from contracts with customers.
We apply a five-step approach as
defined in ASC Topic 606 in
determining the amount and timing of revenue to be recognized:
(1) identifying the contract with
customer; (2) identifying the
performance obligations in the contracts; (3) determining the transaction price;
(4) allocating the transaction
price to the performance obligations in the contract; and
(5) recognizing revenue when the
corresponding performance obligation is satisfied.
Revenue derived from testing services is recognized when testing
services are rendered. Revenue generated from sale of products in
the manufacturing and distribution segments are recognized when
persuasive evidence of an arrangement exists, delivery of the
products has occurred, customer acceptance has been obtained (which
means the significant risks and rewards of ownership have been
transferred to the customer), the price is fixed or determinable
and collectibility is reasonably assured. Certain customers can
request for installation and training services to be performed for
certain products sold in the manufacturing segment. These services
are mainly for helping customers with the test runs of the machines
sold and are considered a separate performance obligation. Such
services can be provided by other entities as well and these do
not significantly modify the
product. The Company recognizes the revenue at a point in time when
the Company has satisfied its performance obligation.
In the real estate segment: (1)
revenue from property development is earned and recognized on the
earlier of the dates when the underlying property is sold or upon
the maturity of the agreement; if this amount is uncollectible, the
agreement empowers the repossession of the property, and
(2) rental revenue is recognized on
a straight-line basis over the terms of the respective leases. This
means that, with respect to a particular lease, actual amounts
billed in accordance with the lease during any given period
may be higher or lower than the
amount of rental revenue recognized for the period. Straight-line
rental revenue is commenced when the tenant assumes possession of
the leased premises. Accrued straight-line rents receivable
represents the amount by which straight-line rental revenue exceeds
rents currently billed in accordance with lease agreements.
GST / Indirect Taxes — The Company’s policy is to present
taxes collected from customers and remitted to governmental
authorities on a net basis. The Company records the amounts
collected as a current liability and relieves such liability upon
remittance to the taxing authority without impacting revenues or
expenses.
Trade Accounts Receivables and Allowance for Doubtful
Accounts — During the normal course of business, the Company
extends unsecured credit to its customers in all segments.
Typically, credit terms require payment to be made between 30 to 90
days from the date of the sale. The Company generally does
not require collateral from our
customers.
The Company’s management considers the following factors when
determining the collectibility of specific customer accounts:
customer creditworthiness, past transaction history with the
customer, current economic industry trends, and changes in customer
payment terms. The Company includes any account balances that are
determined to be uncollectible, along with a general reserve, in
the overall allowance for doubtful accounts. After all attempts to
collect a receivable have failed, the receivable is written off
against the allowance. Based on the information available to
management, the Company believed that its allowance for doubtful
accounts was adequate as of March 31,
2022, and June 30, 2021.
Warranty Costs — The Company provides for the estimated
costs that may be incurred under
its warranty program at the time the sale is recorded in its
manufacturing segment. The Company estimates warranty costs based
on the historical rates of warranty returns. The Company
periodically assesses the adequacy of its recorded warranty
liability and adjusts the amounts as necessary.
Cash and Cash Equivalents — The Company considers all highly
liquid investments with an original maturity of three months or less when purchased to be
cash equivalents.
Term Deposits — Term deposits consist of bank balances and
interest-bearing deposits having maturities of three to six
months.
Restricted Term Deposits — The Company held certain term
deposits in the Singapore and Malaysia operations which were
considered restricted, as they were held as security against
certain facilities granted by the financial institutions
Inventories — Inventories in the Company’s manufacturing and
distribution segments, consisting principally of raw materials,
works in progress, and finished goods, are stated at the lower of
cost, using the first-in,
first-out (“FIFO”) method, or
market value. The semiconductor industry is characterized by rapid
technological change, short-term customer commitments and rapid
fluctuations in demand. Provisions for estimated excess and
obsolete inventory are based on our regular reviews of inventory
quantities on hand and the latest forecasts of product demand and
production requirements from our customers. Inventories are written
down for not-saleable, excess or
obsolete raw materials, works-in-process and finished goods by
charging such write-downs to cost of sales. In addition to
write-downs based on newly introduced parts, statistics and
judgments are used for assessing provisions of the remaining
inventory based on salability and obsolescence.
Property, Plant and Equipment and Investment Properties —
Property, plant and equipment and investment properties are stated
at cost, less accumulated depreciation and amortization.
Depreciation is provided for over the estimated useful lives of the
assets using the straight-line method. Amortization of leasehold
improvements is provided for over the lease terms or the estimated
useful lives of the assets, whichever is shorter, using the
straight-line method.
Maintenance, repairs and minor renewals are charged directly to
expense as incurred. Additions and improvements to the assets are
capitalized. When assets are disposed of, the related cost and
accumulated depreciation thereon are removed from the accounts and
any resulting gain or loss is included in the consolidated
statements of operations and comprehensive income or loss.
Long-Lived Assets and Impairment – The Company’s business
requires heavy investment in manufacturing facilities and equipment
that are technologically advanced but can quickly become
significantly underutilized or rendered obsolete by rapid changes
in demand.
The Company evaluates the long-lived assets, including property,
plant and equipment and investment property, for impairment
whenever events or changes in circumstances indicate that the
carrying value of such assets may
not be recoverable. Factors
considered important that could result in an impairment review
include significant underperformance relative to expected
historical or projected future operating results, significant
changes in the manner of use of the assets or the strategy for our
business, significant negative industry or economic trends, and a
significant decline in the stock price for a sustained period of
time. Impairment is recognized based on the difference between the
fair value of the asset and its carrying value, and fair value is
generally measured based on discounted cash flow analysis if there
is significant adverse change.
The Company applies the provisions of ASC Topic 360, Accounting for the Impairment or
Disposal of Long-Lived Assets (“ASC Topic 360”), to property, plant and equipment. ASC
Topic 360 requires that long-lived
assets be reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset
may not be recoverable through the estimated
undiscounted cash flows expected to result from the use and
eventual disposition of the assets. Whenever any such impairment
exists, an impairment loss will be recognized for the amount by
which the carrying value exceeds the fair value.
Leases - Company as Lessee
Accounting Standards Codification Topic 842 ("ASC Topic 842") introduced new requirements to increase
transparency and comparability among organizations for leasing
transactions for both lessees and lessors. It requires a lessee to
record a right-of-use asset and a lease liability for all leases
with terms longer than 12 months.
These leases will be either finance or operating, with
classification affecting the pattern of expense recognition.
The Company applies the guidance in ASC Topic 842 to its individual leases of assets. When
the Company receives substantially all the economic benefits from
and directs the use of specified property, plant and equipment, the
transactions give rise to leases. The Company’s classes of assets
include real estate leases.
Operating leases are included in operating lease right-of-use
("ROU") assets under the noncurrent asset portion of our
consolidated balance sheets and under the current portion and
noncurrent liabilities portion of our consolidated balance sheets.
ROU assets represent our right to use an underlying asset for the
lease term and lease liabilities represent our obligation to make
lease payments arising from the related lease. Finance leases are
included in property, plant and equipment under the noncurrent
asset portion of our consolidated balance sheets and under the
current portion and noncurrent liabilities portion of our
consolidated balance sheets.
The Company has elected the practical expedient within ASC Topic
842 to not separate lease and non-lease components
within lease transactions for all classes of assets. Additionally,
the Company has elected the short-term lease exception for all
classes of assets, does not apply
the recognition requirements for leases of 12 months or less, and recognizes lease
payments for short-term leases as expense either straight-line over
the lease term or as incurred depending on whether the lease
payments are fixed or variable. These elections are applied
consistently for all leases.
When discount rates implicit in leases cannot be readily
determined, the Company uses the applicable incremental borrowing
rate at lease commencement to perform lease classification tests on
lease components and to measure lease liabilities and ROU assets.
The incremental borrowing rate used by the Company was based on
baseline rates and adjusted by the credit spreads commensurate with
the Company’s secured borrowing rate over a similar term. At each
reporting period when there is a new lease initiated, the rates
established for that quarter will be used.
Leases - Company as Lessor
All the leases under which the Company is the lessor will continue
to be classified as operating leases and sales-type leases under
the standard.
Comprehensive Income or Loss — ASC Topic 220, Reporting Comprehensive Income
(“ASC Topic 220”), establishes
standards for reporting and presentation of comprehensive income or
loss and its components in a full set of general-purpose
consolidated financial statements. The Company has chosen to report
comprehensive income or loss in the statements of operations.
Comprehensive income or loss is comprised of net income or loss and
all changes to shareholders’ equity except those due to investments
by owners and distributions to owners.
Income Taxes — The Company accounts for income taxes using
the liability method in accordance with ASC Topic 740, Accounting for Income Taxes (“ASC
Topic 740”). ASC Topic
740 requires an entity to recognize
deferred tax liabilities and assets. Deferred tax assets and
liabilities are recognized for the future tax consequence
attributable to the difference between the tax bases of assets and
liabilities and their reported amounts in the consolidated
financial statements, which will result in taxable or deductible
amounts in future years. Further, the effects of enacted tax laws
or rate changes are included as part of deferred tax expenses or
benefits in the period that covers the enactment date.
The calculation of tax liabilities involves dealing with
uncertainties in the application of complex global tax regulations.
The Company recognizes potential liabilities for anticipated tax
audit issues in the U.S. and other tax jurisdictions based on its
estimate of whether, and the extent to which, additional taxes will
be due. If payment of these amounts ultimately proves to be
unnecessary, the reversal of the liabilities would result in tax
benefits being recognized in the period when the Company determines
the liabilities are no longer
necessary. If the estimate of tax liabilities proves to be less
than the ultimate assessment, a further charge to expense would
result.
Retained Earnings — It is the intention of the Company to
reinvest earnings of its foreign subsidiaries in the operations of
those subsidiaries. These taxes are undeterminable at this time.
The amount of earnings retained in subsidiaries was $17,803 and
$16,683 at March 31, 2022, and
June 30, 2021 respectively.
Stock-based compensation — The Company calculates
compensation expense related to stock option awards made to
employees and directors based on the fair value of stock-based
awards on the date of grant. The Company determines the grant date
fair value of our stock option awards using the Black-Scholes
option pricing model and for awards without performance conditions,
the related stock-based compensation is recognized over the period
in which a participant is required to provide service in exchange
for the stock-based award, which is generally four years. The Company recognizes
stock-based compensation expense in the consolidated statements of
shareholders’ equity based on awards ultimately expected to vest.
Forfeitures are estimated on the date of grant and revised if
actual or expected forfeiture activity differs materially from
original estimates.
Determining the fair value of stock-based awards at the grant date
requires significant judgment. The determination of the grant date
fair value of stock-based awards using the Black-Scholes option
pricing model is affected by our estimated common stock fair value
as well as other subjective assumptions including the expected term
of the awards, the expected volatility over the expected term of
the awards, expected dividend yield and risk-free interest rates.
The assumptions used in our option pricing model represent
management’s best estimates and are as follows:
|
●
|
Fair Value of Common Stock. We determined the fair value of each
share of underlying common stock based on the closing price of our
common stock on the date of grant.
|
|
●
|
Expected Term. The expected term of employee stock options reflects
the period for which we believe the option will remain outstanding
based on historical experience and future expectations.
|
|
●
|
Expected Volatility. We base expected volatility on our historical
information over a similar expected term.
|
(Loss) / Earnings per Share — Computation of basic earnings
per share is conducted by dividing net income available to common
shares (numerator) by the weighted average number of common shares
outstanding (denominator) during a reporting period. Computation of
diluted earnings per share gives effect to all dilutive potential
common shares outstanding during a reporting period. In computing
diluted earnings per share, the average market price of common
shares for a reporting period is used in determining the number of
shares assumed to be purchased from the exercise of stock
options.
Fair Values of Financial Instruments — Carrying values of
trade account receivables, accounts payable, accrued expenses, and
term deposits approximate their fair value due to their short-term
maturities. Carrying values of the Company’s lines of credit and
long-term debt are considered to approximate their fair value
because the interest rates associated with the lines of credit and
long-term debt are adjustable in accordance with market situations
when the Company tries to borrow funds with similar terms and
remaining maturities. See Note 22
for detailed discussion of the fair value measurement of financial
instruments.
ASC Topic 820, Fair Value
Measurements and Disclosures (“ASC Topic 820”) defines fair value as the price that
would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the
measurement date. The financial assets and financial liabilities
that require recognition under the guidance include
available-for-sale investments, employee deferred compensation plan
and foreign currency derivatives. The guidance establishes a
hierarchy for inputs used in measuring fair value that maximizes
the use of observable inputs and minimizes the use of unobservable
inputs by requiring that the observable inputs be used when
available. Observable inputs are inputs that market participants
would use in pricing the asset or liability developed based on
market data obtained from sources independent of us. Unobservable
inputs are inputs that reflect our assumptions about the
assumptions market participants would use in pricing the asset or
liability developed based on the best information available under
the circumstances. As such, fair value is a market-based measure
considered from the perspective of a market participant who holds
the asset or owes the liability rather than an entity-specific
measure. The hierarchy is broken down into three levels based on the reliability of
inputs as follows:
|
●
|
Level 1—Valuations based on quoted
prices in active markets for identical assets or liabilities that
we have the ability to access. Since valuations are based on quoted
prices that are readily and regularly available in an active
market, valuation of these products does not entail a significant degree of judgment.
Financial assets utilizing Level 1
inputs include U.S. treasuries, most money market funds, marketable
equity securities and our employee deferred compensation plan;
|
|
●
|
Level 2—Valuations based on quoted
prices in markets that are not
active or for which all significant inputs are observable, directly
or indirectly. Financial assets and liabilities utilizing Level
2 inputs include foreign currency
forward exchange contracts, most commercial paper and corporate
notes and bonds; and
|
|
●
|
Level 3—Valuations based on inputs
that are unobservable and significant to the overall fair value
measurement.
|
Concentration of Credit Risk — Financial instruments that
subject the Company to credit risk compose trade account
receivables. The Company performs ongoing credit evaluations of its
customers for potential credit losses. The Company generally does
not require collateral. The Company
believes that its credit policies do not result in significant adverse risk and
historically it has not experienced
significant credit related losses.
Investments — The Company (a) evaluates the sufficiency of
the total equity at risk, (b) reviews the voting rights and
decision-making authority of the equity investment holders as a
group, and whether there are any guaranteed returns, protection
against losses, or capping of residual returns within the group,
and (c) establishes whether activities within the venture are on
behalf of an investor with disproportionately few voting rights in
making this Variable Interest Entity (“VIE”) determination. The
Company would consolidate an investment that is determined to be a
VIE if it was the primary beneficiary. The primary beneficiary of a
VIE is determined by a primarily qualitative approach, whereby the
variable interest holder, if any, has the power to direct
the VIE’s most significant activities and is the primary
beneficiary. A new accounting standard became effective and
changed the method by which the primary beneficiary of a VIE is
determined. Through a primarily qualitative approach, the variable
interest holder who has the power to direct the VIE’s most
significant activities is determined to be the primary beneficiary.
To the extent that the investment does not qualify as VIE, the Company further
assesses the existence of a controlling financial interest under a
voting interest model to determine whether the investment should be
consolidated.
Equity Method — The Company analyzes its investments to
determine if they should be accounted for using the equity method.
Management evaluates both Common Stock and in-substance Common
Stock to determine whether they give the Company the ability to
exercise significant influence over operating and financial
policies of the investment even though the Company holds less than
50% of the Common Stock and
in-substance Common Stock. The net income of the investment, if
any, will be reported as “Equity in earnings of unconsolidated
joint ventures, net of tax” in the Company’s consolidated
statements of operations and comprehensive income.
Cost Method — Investee companies not accounted for under the consolidation or
the equity method of accounting are accounted for under the cost
method of accounting. Under this method, the Company’s share of the
earnings or losses of such investee companies is not included in the consolidated balance
sheet or statements of operations and comprehensive income or loss.
However, impairment charges are recognized in the consolidated
statements of operations and comprehensive income or loss. If
circumstances suggest that the value of the investee company has
subsequently recovered, such recovery is not recorded.
Loan Receivables from Property Development Projects — The
loan receivables from property development projects are classified
as current assets, carried at face value, and are individually
evaluated for impairment. The allowance for loan losses
reflects management’s best estimate of probable losses determined
principally on the basis of historical experience and specific
allowances for known loan accounts. All loans or portions thereof
deemed to be uncollectible or to require an excessive collection
cost are written off to the allowance for losses.
Interest income on the loan receivables from property development
projects are recognized on an accrual basis. Discounts and premiums
on loans are amortized to income using the interest method over the
remaining period to contractual maturity. The amortization of
discounts into income is discontinued on loans that are
contractually 90 days past due or
when collection of interest appears doubtful.
Contingent Liabilities — Certain conditions may exist as of the date the consolidated
financial statements are issued, which may result in a loss to the Company, but
which will only be resolved when one or more future events occur or fail to
occur. The Company’s management and its legal counsel assess such
contingent liabilities, and such assessment inherently involves an
exercise of judgment. In assessing loss contingencies related to
legal proceedings that are pending against the Company or
unasserted claims that may result
in such proceedings, the Company’s legal counsel evaluates the
perceived merits of any legal proceedings or unasserted claims, as
well as the perceived merits of the amount of relief sought or
expected to be sought therein.
If the assessment of a contingency indicates that it is probable
that a material loss has been incurred and the amount of the
liability can be estimated, then the estimated liability would be
accrued in the Company’s consolidated financial statements. If the
assessment indicates that a potential material loss contingency is
not probable, but is reasonably
possible, or is probable but cannot be estimated, then the nature
of the contingent liability, together with an estimate of the range
of possible loss if determinable and material, would be
disclosed.
Loss contingencies considered remote are generally not disclosed unless they involve guarantees,
in which case the nature of the guarantee would be disclosed.
Consolidation of subsidiaries- A subsidiary is an investee
that is controlled by the Group. The Group controls an investee
when it is exposed, or has rights, to variable returns from its
involvement with the investee and has the ability to affect those
returns through its power over the investee. The Group elects
voting interest entity model (referred to as the “VOE” model) in
consolidation as the Group has a controlling financial interest in
an entity. A controlling financial interest is generally based on
the concept that a reporting entity should have the unilateral
right to make the significant financial and operating decisions of
an entity without regard to probability. In the Company’s separate
financial statements, investments in subsidiaries are accounted for
at cost less impairment losses.
The consolidated financial statements of Group include the accounts
of Trio-Tech International and its subsidiaries. Intercompany
transactions and balances have been eliminated.
2. NEW
ACCOUNTING PRONOUNCEMENTS
In March 2020, FASB issued ASU
2020-04 ASC Topic 848: Reference Rate Reform: Facilitation
of the Effects of Reference Rate Reform on Financial Reporting,
which provides optional expedients and exceptions for applying U.S.
GAAP to contracts, hedging relationships and other transactions
affected by the discontinuation of the London Interbank Offered
Rate (“LIBOR”) or by another reference rate expected to be
discontinued. The amendments are effective for all entities as of
March 12, 2020, and the Company
may elect to apply the amendments
prospectively through December 31,
2022. The Company has completed its assessment and concluded
that this update has no significant
impact to the Company’s consolidated financial statements.
In June 2016, FASB issued ASU
2016-13 ASC Topic 326, Financial Instruments — Credit
Losses (“ASC Topic 326”) for
the measurement of all expected credit losses for financial assets
held at the reporting date based on historical experience, current
conditions, and reasonable and supportable forecasts. Financial
institutions and other organizations will now use forward-looking
information to better inform their credit loss estimates. Many of
the loss estimation techniques applied today will still be
permitted, although the inputs to those techniques will change to
reflect the full amount of expected credit losses. ASC Topic
326 is effective for the Company
for annual periods beginning after December 15, 2022. The Company has completed
its assessment and concluded that this update has no significant impact to the Company’s
consolidated financial statements.
Other new pronouncements issued but not yet effective until after March 31, 2022, are not expected to have a significant effect on
the Company’s consolidated financial position or results of
operations.
3. TERM
DEPOSITS
|
|
Mar. 31,
2022
(Unaudited)
|
|
|
June 30,
2021
|
|
|
|
|
|
|
|
|
|
|
Short-term deposits
|
|
$ |
4,961 |
|
|
$ |
6,353 |
|
Currency translation effect on short-term deposits
|
|
|
(8 |
) |
|
|
298 |
|
Total short-term deposits
|
|
|
4,953 |
|
|
|
6,651 |
|
Restricted term deposits
|
|
|
1,736 |
|
|
|
1,682 |
|
Currency translation effect on restricted term deposits
|
|
|
(1 |
) |
|
|
59 |
|
Total restricted term deposits
|
|
|
1,735 |
|
|
|
1,741 |
|
Total term deposits
|
|
$ |
6,688 |
|
|
$ |
8,392 |
|
Restricted deposits represent the amount of cash pledged to secure
loans payable to financial institutions and serve as collateral for
public utility agreements such as electricity and water, and
performance bonds related to customs duty payable. Restricted
deposits are classified as noncurrent assets, as they relate to
long-term obligations and will become unrestricted only upon
discharge of the obligations. Short-term deposits represent bank
deposits, which do not qualify as
cash equivalents.
4. TRADE
ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS
Accounts receivable are customer obligations due under normal trade
terms. The Company performs continuing credit evaluations of its
customers’ financial conditions, and although management generally
does not require collateral,
letters of credit may be required
from the customers in certain circumstances.
Senior management reviews accounts receivable on a periodic basis
to determine if any receivables will potentially be uncollectible.
Management includes any accounts receivable balances that are
determined to be uncollectible in the allowance for doubtful
accounts. After all reasonable attempts to collect a receivable
have failed, the receivable is written off against the
allowance. Based on the information available, management
believed the allowance for doubtful accounts as of March 31, 2022, and June 30, 2021, was adequate.
The following table represents the changes in the allowance for
doubtful accounts:
|
|
Mar. 31,
2022
(Unaudited)
|
|
|
June 30,
2021
|
|
Beginning
|
|
$ |
311 |
|
|
$ |
314 |
|
Additions charged to expenses
|
|
|
44 |
|
|
|
5 |
|
Recovered
|
|
|
(105 |
) |
|
|
(14 |
)
|
Write-off
|
|
|
- |
|
|
|
(16 |
)
|
Currency translation effect
|
|
|
3 |
|
|
|
22 |
|
Ending
|
|
$ |
253 |
|
|
$ |
311 |
|
5. LOANS
RECEIVABLE FROM PROPERTY DEVELOPMENT PROJECTS
The following table presents Trio-Tech (Chongqing) Co. Ltd
(“TTCQ”)’s loan receivables from property development projects in
China as of March 31, 2022.
|
Loan Expiry
Date
|
|
Loan Amount
(RMB)
|
|
|
Loan Amount
(U.S. Dollars)
|
|
Short-term loan receivables
|
|
|
|
|
|
|
|
|
|
JiangHuai (Project – Yu Jin Jiang An)
|
May 31, 2013
|
|
|
2,000 |
|
|
|
314 |
|
Less: allowance for doubtful receivables
|
|
|
|
(2,000 |
)
|
|
|
(314 |
)
|
Net loan receivables from property development projects
|
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
Long-term loan receivables
|
|
|
|
|
|
|
|
|
|
Jun Zhou Zhi Ye
|
Oct 31, 2016
|
|
|
5,000 |
|
|
|
788 |
|
Less: transfer – downpayment for purchase of investment
property
|
|
|
|
(5,000 |
)
|
|
|
(788 |
)
|
Net loan receivables from property development projects
|
|
|
|
- |
|
|
|
- |
|
The short-term loan receivables amounting to renminbi (“RMB”)
2,000, or approximately $314
arose due to TTCQ entering into a Memorandum Agreement with
JiangHuai Property Development Co. Ltd. (“JiangHuai”) to invest in
their property development projects (Project – Yu Jin Jiang An)
located in Chongqing City, China in fiscal 2011. Based on TTI’s financial policy, a
provision for doubtful receivables of $314 on the investment in
JiangHuai was recorded during fiscal 2014. TTCQ did not generate other income from JiangHuai for
the quarter ended March 31, 2022 or
for the fiscal year ended June 30,
2021. TTCQ is in the legal process of recovering the
outstanding amount of approximately $314.
The loan amounting to RMB 5,000, or approximately $788, arose due
to TTCQ entering into a Memorandum Agreement with JiaSheng Property
Development Co. Ltd. (“JiaSheng”) to invest in their property
development projects (Project B-48
Phase 2) located in Chongqing City,
China in fiscal 2011. The amount
was unsecured and repayable at the end of the term. The book value
of the loan receivable approximates its fair value. During fiscal
year 2015, the loan receivable was
transferred to down payment for purchase of investment property
that is being developed in the Singapore Themed Resort Project (See
Note 8).
6. INVENTORIES
Inventories consisted of the following:
|
|
Mar. 31,
2022
(Unaudited)
|
|
|
June 30,
2021
|
|
|
|
|
|
|
|
|
|
|
Raw materials
|
|
$ |
1,340 |
|
|
$ |
1,152 |
|
Work in progress
|
|
|
1,332 |
|
|
|
1,218 |
|
Finished goods
|
|
|
319 |
|
|
|
325 |
|
Less: provision for obsolete inventories
|
|
|
(709 |
)
|
|
|
(679 |
)
|
Currency translation effect
|
|
|
(10 |
)
|
|
|
64 |
|
|
|
$ |
2,272 |
|
|
$ |
2,080 |
|
The following table represents the changes in provision for
obsolete inventories:
|
|
Mar. 31,
2022
(Unaudited)
|
|
|
June 30,
2021
|
|
|
|
|
|
|
|
|
|
|
Beginning
|
|
$ |
679 |
|
|
$ |
678 |
|
Additions charged to expenses
|
|
|
25 |
|
|
|
13 |
|
Usage – disposition
|
|
|
- |
|
|
|
(28 |
) |
Currency translation effect
|
|
|
5 |
|
|
|
16 |
|
Ending
|
|
$ |
709 |
|
|
$ |
679 |
|
7. INVESTMENT
PROPERTIES
The following table presents the Company’s investment in properties
in China (with estimated 20 years useful life in years) as of
March 31, 2022. The exchange rate
is based on the market rate as of March
31, 2022.
|
Investment
Date / Reclassification Date
|
|
Investment
Amount (RMB)
|
|
|
Investment Amount
(U.S. Dollars)
|
|
Purchase of rental property – Property I – MaoYe Property
|
Jan 04, 2008
|
|
|
5,554 |
|
|
|
894 |
|
Currency translation
|
|
|
|
- |
|
|
|
(87 |
)
|
Reclassification as “Assets held for sale”
|
July 01, 2019
|
|
|
(5,554 |
)
|
|
|
(807 |
)
|
Reclassification from “Assets held for sale”
|
Mar 31, 2020
|
|
|
2,024 |
|
|
|
301 |
|
|
|
|
|
2,024 |
|
|
|
301 |
|
Purchase of rental property – Property II - JiangHuai
|
Jan 06, 2010
|
|
|
3,600 |
|
|
|
580 |
|
Purchase of rental property – Property III - FuLi
|
Apr 08, 2010
|
|
|
4,025 |
|
|
|
648 |
|
Currency translation
|
|
|
|
- |
|
|
|
(15 |
)
|
Gross investment in rental property
|
|
|
|
9,649 |
|
|
|
1,514 |
|
Accumulated depreciation on rental property
|
Mar 31, 2022
|
|
|
(7,402 |
)
|
|
|
(1,145 |
)
|
Reclassified as “Assets held for sale”- MaoYe Property
|
July 01, 2018
|
|
|
2,822 |
|
|
|
410 |
|
Reclassification from “Assets held for sale”- MaoYe Property
|
Mar 31, 2019
|
|
|
(1,029 |
)
|
|
|
(143 |
)
|
|
|
|
|
(5,488 |
)
|
|
|
(878 |
)
|
Net investment in property – China
|
|
|
|
4,161 |
|
|
|
636 |
|
The following table presents the Company’s investment in properties
in China (with estimated 20 years useful life in years) as of
June 30, 2021. The exchange rate is
based on the market rate as of June 30,
2021.
|
Investment
Date / Reclassification Date
|
|
Investment
Amount (RMB)
|
|
|
Investment Amount
(U.S. Dollars)
|
|
Purchase of rental property – Property I – MaoYe Property
|
Jan 04, 2008
|
|
|
5,554 |
|
|
|
894 |
|
Currency translation
|
|
|
|
- |
|
|
|
(87 |
)
|
Reclassification as “Assets held for sale”
|
Jul 01, 2018
|
|
|
(5,554 |
)
|
|
|
(807 |
)
|
Reclassification from “Assets held for sale”
|
Mar 31, 2019
|
|
|
2,024 |
|
|
|
301 |
|
|
|
|
|
2,024 |
|
|
|
301 |
|
Purchase of rental property – Property II - JiangHuai
|
Jan 06, 2010
|
|
|
3,600 |
|
|
|
580 |
|
Purchase of rental property – Property III - FuLi
|
Apr 08, 2010
|
|
|
4,025 |
|
|
|
648 |
|
Currency translation
|
|
|
|
- |
|
|
|
(36 |
)
|
Gross investment in rental property
|
|
|
|
9,649 |
|
|
|
1,493 |
|
Accumulated depreciation on rental property
|
Jun 30, 2021
|
|
|
(7,040 |
)
|
|
|
(1,079 |
)
|
Reclassified as “Assets held for sale” - MaoYe Property
|
Jul 01, 2019
|
|
|
2,822 |
|
|
|
410 |
|
Reclassification from “Assets held for sale” - MaoYe Property
|
Mar 31, 2020
|
|
|
(1,029 |
)
|
|
|
(143 |
)
|
|
|
|
|
(5,247 |
)
|
|
|
(812 |
)
|
Net investment in properties – China
|
|
|
|
4,402 |
|
|
|
681 |
|
Rental Property I - MaoYe Property
In fiscal 2008, TTCQ purchased an
office in Chongqing, China from MaoYe Property Ltd. (“MaoYe”), for
a total cash purchase price of RMB 5,554, or approximately
$894.
Property purchased from MaoYe generated a rental income $nil and $4 during the three and nine months ended March 31, 2022, as compared to $6 and $9 for
the same periods, respectively, in last fiscal year.
Depreciation expense for MaoYe was $4 and $12 for the three and nine months ended March 31, 2022 and 2021, respectively as compared to $4 and $11
for the same period in the lsat fiscal year.
Rental Property II - JiangHuai
In fiscal year 2010, TTCQ purchased
eight units of commercial property
in Chongqing, China from Chongqing JiangHuai Real Estate
Development Co. Ltd. (“JiangHuai”) for a total purchase price of
RMB 3,600, or approximately $580. TTCQ has yet to receive the title
deed for these properties. TTCQ was in the legal process of
obtaining the title deed until the developer encountered cash flow
difficulties in recent years. Since fiscal year 2018, JiangHuai has been under liquidation
and is now undergoing asset distribution. During the third quarter of fiscal 2022, TTCQ agreed to the local court’s
administration’s proposal for the amounts owed by JiangHuai to be
paid to TTCQ in the form of assets after the fall through of the
three auctions conducted. Nonetheless, this is not expected to affect the property’s
recoverable amount but, in view of the COVID-19 pandemic and the complexity of this case,
the process and execution will take some time.
Property purchased from JiangHuai did not generate any rental income for the
three and nine months ended March 31, 2022 and 2021.
Depreciation expense for JiangHuai was $7 and $21 for the
three and nine months ended March 31, 2022, as compared to $6 and $19 for
the same period in last fiscal year.
Rental Property III – FuLi
In fiscal 2010, TTCQ entered into a
Memorandum Agreement with Chongqing FuLi Real Estate Development
Co. Ltd. (“FuLi”) to purchase two commercial properties
totaling 311.99 square meters (“office space”) located in Jiang Bei
District Chongqing. The total purchase price committed and paid was
RMB 4,025, or
approximately $648. The development was completed, the
property was handed over to TTCQ in April 2013 and the title deed was received
during the third quarter of fiscal
2014.
One of the two
commercial properties was leased from TTCQ by a third party under a two-year lease to rent out the
154.49 square meter space at a monthly rate of RMB9, or approximately $1,
commencing from May 21, 2021, to
May 23, 2023.
For the other leased property, TTCQ renewed the lease agreement to
rent out the 161 square meter space at a monthly rate of
RMB10, or
approximately $1, from November 1,
2019, to October 31, 2020.
After which, TTCQ renewed the lease agreement at a monthly rate of
RMB10, or
approximately $1, from November 1,
2020, to April 30, 2021, and
May 1, 2021, to October 31, 2021. As the space is currently
vacant, TTCQ is actively searching for a tenant for this space.
Properties purchased from FuLi generated a rental income of $4 and
$19 for the three and nine months ended March 31, 2022, as compared to $5 and $12 for
the same period in the last fiscal year.
Depreciation expense for FuLi was $8 and $23 for the three and nine months ended March 31, 2022, respectively, as compared to
$7 and $22 for the same period in the last fiscal year.
Summary
Total rental income for all investment properties in China was $4
and $23 for the three and
nine months ended March 31, 2022, as compared to $11 and $21
for the same periods, respectively, in the last fiscal year.
Depreciation expenses for all investment properties in China were
$19 and $56 for the three and
nine months ended March 31, 2022, respectively, as compared to
$17 and $52 same periods, respectively, in the last fiscal
year.
8. OTHER
ASSETS
Other assets consisted of the following:
|
|
Mar. 31,
2022
(Unaudited)
|
|
|
June 30,
2021
|
|
Down payment for purchase of investment properties *
|
|
$ |
- |
|
|
$ |
- |
|
Down payment for purchase of property, plant and equipment
|
|
|
6 |
|
|
|
372 |
|
Deposits for rental and utilities and others
|
|
|
153 |
|
|
|
160 |
|
Currency translation effect
|
|
|
(18 |
) |
|
|
(270 |
)
|
Total
|
|
$ |
141 |
|
|
$ |
262 |
|
*Down payment for purchase of investment properties included:
|
|
RMB
|
|
|
US Dollars
|
|
Original Investment (10% of Jun Zhou equity)
|
|
$ |
10,000 |
|
|
$ |
1,606 |
|
Less: Management Fee
|
|
|
(5,000 |
) |
|
|
(803 |
)
|
Net Investment
|
|
|
5,000 |
|
|
|
803 |
|
Less: Share of Loss on Joint Venture
|
|
|
(137 |
)
|
|
|
(22 |
)
|
Net Investment as Down Payment (Note *a)
|
|
|
4,863 |
|
|
|
781 |
|
Loans Receivable
|
|
|
5,000 |
|
|
|
788 |
|
Interest Receivable
|
|
|
1,250 |
|
|
|
197 |
|
Less: Impairment of Interest
|
|
|
(906 |
) |
|
|
(143 |
)
|
Transferred to Down Payment (Note *b)
|
|
|
5,344 |
|
|
|
842 |
|
* Down Payment for Purchase of Investment Properties
|
|
|
10,207 |
|
|
|
1,623 |
|
Less: Provision of Impairment loss on other assets
|
|
|
(10,207 |
)
|
|
|
(1,623 |
)
|
* Down Payment for Purchase of Investment Properties
|
|
|
- |
|
|
|
- |
|
a)
|
In fiscal year 2011, the Company
signed a Joint Venture agreement (“agreement”) with Jia Sheng
Property Development Co. Ltd. (“Developer”) to form a new company,
Jun Zhou Co., Limited (“Joint
Venture” or “Jun Zhou”) to joint
develop the “Singapore Themed Park” project (the “project”), where
the Company paid RMB 10 million for
a 10% investment in the joint venture. The Developer paid the
Company a management fee of RMB5 million in cash upon signing
of the agreement with a remaining fee of RMB5 million payable upon
fulfilment of certain conditions in accordance with the agreement.
The Company further reduced its investment by RMB 137, or
approximately $22,
towards the losses from operations incurred by the joint
venture.
|
In fiscal year 2014, the Company
disposed of its entire 10% interest in the joint
venture. The Company recognized the disposal of its 10% investment
in Jun Zhou based on the recorded
net book value of RMB5 million or equivalent to
$788, from net considerations paid, in accordance with US GAAP
under ASC Topic 845 Non-monetary
Consideration, and it’s presented under “Other Assets” as
noncurrent assets to defer the recognition of the gain on the
disposal of the 10% interest in the joint venture investment until
such time that the consideration is paid, so that the gain can be
ascertained. As of Mar 31, 2022,
asset reorganization undertaken by local government still in
process.
b)
|
Amounts of RMB 5,000, or approximately $788, as disclosed in Note
5, plus the interest receivable on
long term loan receivable of RMB 1,250, or approximately $197, and
impairment on interest of RMB 906, or approximately $143.
|
The shop lots are to be delivered to TTCQ upon completion of the
construction of the shop lots in Singapore Themed Resort Project.
The initial targeted date of completion was in fiscal year
2017. However, the progress has
been delayed as the developer is currently undergoing asset
reorganization process, to re-negotiate with their creditors to
complete the project.
During the fourth quarter of fiscal
2021, the Company accrued an
impairment charge of $1,580 related to the doubtful recovery of the
down payment on shop lots in the Singapore Theme Resort Project in
Chongqing, China, which the impairment loss translated based on the
exchange rate used in the fiscal year 2021. The Company accounted for this noncash
impairment charge because of increased uncertainties regarding the
project’s viability given the developer’s weakening financial
condition as well as uncertainties arising from the negative real
estate environment in China, implementation of control measures on
real estate lending and its relevant government policies, together
with effects of the ongoing pandemic.
9. LINES OF CREDIT
Carrying value of the Company’s lines of credit approximates its
fair value because the interest rates associated with the lines of
credit are adjustable in accordance with market situations when the
Company borrowed funds with similar terms and remaining
maturities.
The Company’s credit rating provides it with ready and adequate
access to funds in global markets.
As of March 31, 2022, the Company
had certain lines of credit that are collateralized by restricted
deposits.
Entity with
|
|
Type of
|
|
Interest
|
|
Expiration
|
|
|
Credit
|
|
|
Unused
|
|
Facility
|
|
Facility
|
|
Rate
|
|
Date
|
|
|
Limitation
|
|
|
Credit
|
|
Trio-Tech International Pte. Ltd., Singapore
|
|
Lines of Credit
|
|
Ranging from 1.85% to 5.5%,
SIBOR rate +1.25% and LIBOR rate +1.25%
|
|
|
- |
|
|
$ |
4,214 |
|
|
$ |
3,900 |
|
Universal (Far East) Pte. Ltd. |
|
Lines of Credit |
|
Ranging from 1.85% to
5.5% |
|
|
- |
|
|
$ |
1,109 |
|
|
$ |
900 |
|
Trio-Tech Malaysia Sdn. Bhd. |
|
Revolving Credit |
|
Cost of Funds Rate
+2% |
|
|
- |
|
|
$ |
358 |
|
|
$ |
358 |
|
As of June 30, 2021, the Company
had certain lines of credit that are collateralized by restricted
deposits.
Entity with
|
|
Type of
|
|
Interest
|
|
Expiration
|
|
|
Credit
|
|
|
Unused
|
|
Facility
|
|
Facility
|
|
Rate
|
|
Date
|
|
|
Limitation
|
|
|
Credit
|
|
Trio-Tech International Pte. Ltd., Singapore
|
|
Lines of Credit
|
|
Ranging from 1.85% to 5.5%, SIBOR rate
+1.25% and LIBOR rate +1.30%
|
|
|
- |
|
|
$ |
4,806 |
|
|
$ |
4,806 |
|
Universal (Far East) Pte. Ltd. |
|
Lines of Credit |
|
Ranging from 1.85% to 5.5% |
|
|
- |
|
|
$ |
359 |
|
|
$ |
187 |
|
Trio-Tech Malaysia Sdn. Bhd. |
|
Revolving Credit |
|
Cost of Funds Rate +2% |
|
|
- |
|
|
$ |
350 |
|
|
$ |
350 |
|
10. ACCRUED
EXPENSES
Accrued expenses consisted of the following:
|
|
Mar. 31,
2022
(Unaudited)
|
|
|
June 30,
2021
|
|
Payroll and related costs
|
|
$ |
1,641 |
|
|
$ |
1,362 |
|
Commissions
|
|
|
81 |
|
|
|
51 |
|
Legal and audit
|
|
|
412 |
|
|
|
321 |
|
Sales tax
|
|
|
488 |
|
|
|
9 |
|
Utilities
|
|
|
153 |
|
|
|
91 |
|
Warranty
|
|
|
16 |
|
|
|
14 |
|
Accrued purchase of materials and property, plant and equipment
|
|
|
362 |
|
|
|
144 |
|
Provision for reinstatement
|
|
|
309 |
|
|
|
290 |
|
Deferred income
|
|
|
60 |
|
|
|
67 |
|
Other accrued expenses
|
|
|
347 |
|
|
|
279 |
|
Currency translation effect
|
|
|
1 |
|
|
|
62 |
|
Total
|
|
$ |
3,870 |
|
|
$ |
2,690 |
|
11. ASSURANCE
WARRANTY ACCRUAL
The Company provides for the estimated costs that may be incurred under its warranty program at
the time the sale is recorded. The warranty period of
the products manufactured by the Company is generally one year or the warranty period agreed upon
with the customer. The Company estimates the warranty
costs based on the historical rates of warranty returns. The
Company periodically assesses the adequacy of its recorded warranty
liability and adjusts the amounts as necessary.
|
|
Mar. 31,
2022
(Unaudited)
|
|
|
June 30,
2021
|
|
Beginning
|
|
$ |
14 |
|
|
$ |
12 |
|
Additions charged to cost and expenses
|
|
|
2 |
|
|
|
7 |
|
Reversal
|
|
|
- |
|
|
|
(4 |
)
|
Currency translation effect
|
|
|
- |
|
|
|
(1 |
)
|
Ending
|
|
$ |
16 |
|
|
$ |
14 |
|
12. BANK
LOANS PAYABLE
Bank loans payable consisted of the following:
|
|
Mar. 31, 2022
(Unaudited)
|
|
|
June 30, 2021
|
|
Note payable denominated in RM for expansion plans in Malaysia,
maturing in August 2028, bearing interest at the bank’s prime rate
less 2.00% (3.60% for March 31, 2022 and June 30, 2021) per annum,
with monthly payments of principal plus interest through August
2028, collateralized by the acquired building with a carrying value
of $2,543 and $2,579, as at March 31, 2022 and June 30, 2021,
respectively.
|
|
|
1,571 |
|
|
|
1,885 |
|
|
|
|
|
|
|
|
|
|
Financing arrangement at fixed interest rate 3.2% per annum, with
monthly payments of principal plus interest through July 2025.
|
|
|
145 |
|
|
|
175 |
|
|
|
|
|
|
|
|
|
|
Financing arrangement at fixed interest rate 3.0% per annum, with
monthly payments of principal plus interest through Dec 2026.
|
|
|
246 |
|
|
|
- |
|
Total bank loans payable
|
|
$ |
1,962 |
|
|
$ |
2,060 |
|
|
|
|
|
|
|
|
|
|
Current portion of bank loans payable
|
|
|
498 |
|
|
|
428 |
|
Currency translation effect on current portion of bank loans
|
|
|
(5 |
)
|
|
|
11 |
|
Current portion of bank loans payable
|
|
|
493 |
|
|
|
439 |
|
Long-term portion of bank loans payable
|
|
|
1,487 |
|
|
|
1,564 |
|
Currency translation effect on long-term portion of bank loans
|
|
|
(17 |
)
|
|
|
57 |
|
Long-term portion of bank loans payable
|
|
$ |
1,470 |
|
|
$ |
1,621 |
|
Future minimum payments (excluding interest) as at March 31, 2022, were as follows:
Remainder of fiscal 2022
|
|
$ |
459 |
|
2023
|
|
|
512 |
|
2024
|
|
|
311 |
|
2025
|
|
|
233 |
|
2026
|
|
|
227 |
|
Thereafter
|
|
|
221 |
|
Total obligations and commitments
|
|
$ |
1,962 |
|
Future minimum payments (excluding interest) as at June 30, 2021, were as
follows:
2022
|
|
$ |
439 |
|
2023
|
|
|
457 |
|
2024
|
|
|
462 |
|
2025
|
|
|
208 |
|
2026
|
|
|
171 |
|
Thereafter
|
|
|
323 |
|
Total obligations and commitments
|
|
$ |
2,060 |
|
13. COMMITMENTS AND
CONTINGENCIES
Trio-Tech (Malaysia) Sdn. Bhd. has no capital commitments as at
March 31, 2022, as compared to
capital commitment of $93 as at June 30,
2021.
The Company is, from time to time, the subject of litigation claims
and assessments arising out of matters occurring in its normal
business operations. In the opinion of management, resolution of
these matters will not have a material adverse
effect on the Company’s financial statements.
14. BUSINESS
SEGMENTS
The Company generates revenue primarily from 3 different segments: Manufacturing, Testing
and Distribution. The Company accounts for a contract with a
customer when there is approval and commitment from both parties,
the rights of the parties are identified, payment terms are
identified, the contract has commercial substance and
collectibility of consideration is probable. The Company’s revenues
are measured based on consideration stipulated in the arrangement
with each customer, net of any sales incentives and amounts
collected on behalf of third
parties, such as sales taxes. The revenues are recognized as
separate performance obligations that are satisfied by transferring
control of the product or service to the customer.
The revenue allocated to individual countries was based on where
the customers were located. The allocation of the cost of
equipment, the current year investment in new equipment and
depreciation expense have been made based on the primary purpose
for which the equipment was acquired.
Significant Judgments
The Company’s arrangements with its customers include various
combinations of products and services, which are generally capable
of being distinct and accounted for as separate performance
obligations. A product or service is considered distinct if it is
separately identifiable from other deliverables in the arrangement
and if a customer can benefit from it on its own or with other
resources that are readily available to the customer.
The Company allocates the transaction price to each performance
obligation on a relative standalone selling price basis (“SSP”).
Determining the SSP for each distinct performance obligation and
allocation of consideration from an arrangement to the individual
performance obligations and the appropriate timing of revenue
recognition are significant judgments with respect to these
arrangements. The Company typically establishes the SSP based on
observable prices of products or services sold separately in
comparable circumstances to similar clients. The Company may estimate SSP by considering internal
costs, profit objectives and pricing practices in certain
circumstances.
Warranties, discounts and allowances are estimated using historical
and recent data trends. The Company includes estimates in the
transaction price only to the extent that a significant reversal of
revenue is not probable in
subsequent periods. The Company’s products and services are
generally not sold with a right of
return, nor has the Company experienced significant returns from or
refunds to its customers.
Manufacturing
The Company primarily derives revenue from the sale of both
front-end and back-end semiconductor test equipment and related
peripherals, maintenance and support of all these products,
installation and training services and the sale of spare parts. The
Company’s revenues are measured based on consideration stipulated
in the arrangement with each customer, net of any sales incentives
and amounts collected on behalf of third parties, such as sales taxes.
The Company recognizes revenue at a point in time when the Company
has satisfied its performance obligation by transferring control of
the product to the customer. The Company uses judgment to evaluate
whether the control has transferred by considering several
indicators, including:
|
●
|
whether the Company has a present right to payment;
|
|
●
|
the customer has legal title;
|
|
●
|
the customer has physical possession;
|
|
●
|
the customer has significant risk and rewards of ownership; and
|
|
●
|
the customer has accepted the product, or whether customer
acceptance is considered a formality based on history of acceptance
of similar products (for example, when the customer has previously
accepted the same equipment, with the same specifications, and when
we can objectively demonstrate that the tool meets all the required
acceptance criteria, and when the installation of the system is
deemed perfunctory).
|
Not all indicators need to be met
for the Company to conclude that control has transferred to the
customer. In circumstances in which revenue is recognized prior to
the product acceptance, the portion of revenue associated with its
performance obligations of product installation and training
services are deferred and recognized upon acceptance.
The majority of sales under the Manufacturing segment include a
standard 12-month warranty. The
Company has concluded that the warranty provided for standard
products are assurance type warranties and are not separate performance obligations.
Warranty provided for customized products are service warranties
and are separate performance obligations. Transaction prices are
allocated to this performance obligation using cost plus method.
The portion of revenue associated with warranty service is deferred
and recognized as revenue over the warranty period, as the customer
simultaneously receives and consumes the benefits of warranty
services provided by the Company.
Testing
The Company renders testing services to manufacturers and
purchasers of semiconductors and other entities who either lack
testing capabilities or whose in-house screening facilities are
insufficient. The Company primarily derives testing revenue from
burn-in services, manpower supply and other associated services.
SSP is directly observable from the sales orders. Revenue is
allocated to performance obligations satisfied at a point in time
depending upon terms of the sales order. Generally, there is
no other performance obligation
other than what has been stated inside the sales order for each of
these sales.
Terms of contract that may indicate
potential variable consideration include warranty, late delivery
penalty and reimbursement to solve nonconformance issues for
rejected products. Based on historical and recent data trends, it
is concluded that these terms of the contract do not represent potential variable
consideration. The transaction price is not contingent on the occurrence of any
future event.
Distribution
The Company distributes complementary products, particularly
equipment, industrial products and components by manufacturers
mainly from the U.S., Europe, Taiwan and Japan. The Company
recognizes revenue from product sales at a point in time when the
Company has satisfied its performance obligation by transferring
control of the product to the customer. The Company uses judgment
to evaluate whether control has transferred by considering several
indicators discussed above. The Company recognizes the revenue at a
point in time, generally upon shipment or delivery of the products
to the customer or distributors, depending upon terms of the sales
order.
All intersegment revenue was from the manufacturing segment to the
testing and distribution segments. Total intersegment revenue was
$232 for the three months ended
March 31, 2022, as compared to $375
for the same period in the last fiscal year. Corporate assets
mainly consisted of cash and prepaid expenses. Corporate expenses
mainly consisted of stock option expenses, salaries, insurance,
professional expenses and directors' fees. Corporate expenses are
allocated to the four
segments. The following segment information table includes segment
operating income or loss after including the corporate expenses
allocated to the segments, which gets eliminated in the
consolidation.
The following segment information is unaudited for the nine months ended March 31, 2022 and March 31, 2021:
Business Segment Information:
|
Nine Months
Ended
Mar. 31,
|
|
Net
Revenue
|
|
|
Operating
Income / (Loss)
|
|
|
Total
Assets
|
|
|
Depr.
And
Amort.
|
|
|
Capital
Expenditures
|
|
Manufacturing
|
2022
|
|
$ |
10,187 |
|
|
|
107 |
|
|
|
14,204 |
|
|
|
318 |
|
|
|
103 |
|
|
2021
|
|
$ |
9,324 |
|
|
|
277 |
|
|
|
12,576 |
|
|
|
310 |
|
|
|
214 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Testing Services
|
2022
|
|
|
13,983 |
|
|
|
1,000 |
|
|
|
24,030 |
|
|
|
1,884 |
|
|
|
1,040 |
|
|
2021
|
|
|
10,018 |
|
|
|
(993 |
)
|
|
|
21,364 |
|
|
|
1,859 |
|
|
|
407 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distribution
|
2022
|
|
|
8,038 |
|
|
|
1,108 |
|
|
|
1,601 |
|
|
|
- |
|
|
|
- |
|
|
2021
|
|
|
3,790 |
|
|
|
407 |
|
|
|
983 |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real Estate
|
2022
|
|
|
23 |
|
|
|
(86 |
)
|
|
|
1,730 |
|
|
|
61 |
|
|
|
1 |
|
|
2021
|
|
|
22 |
|
|
|
(84 |
)
|
|
|
3,784 |
|
|
|
55 |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate &
|
2022
|
|
|
- |
|
|
|
(632 |
)
|
|
|
238 |
|
|
|
- |
|
|
|
- |
|
Unallocated
|
2021
|
|
|
- |
|
|
|
(36 |
)
|
|
|
418 |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company
|
2022
|
|
$ |
32,231 |
|
|
|
1,496 |
|
|
|
41,803 |
|
|
|
2,263 |
|
|
|
1,144 |
|
|
2021
|
|
$ |
23,154 |
|
|
|
(429 |
)
|
|
|
39,125 |
|
|
|
2,224 |
|
|
|
621 |
|
The following segment information is unaudited for the three months ended March 31, 2022, and March 31, 2021:
Business Segment Information:
|
Three Months
Ended
Mar. 31,
|
|
Net
Revenue
|
|
|
Operating
Income / (Loss)
|
|
|
Total
Assets
|
|
|
Depr.
And
Amort.
|
|
|
Capital
Expenditures
|
|
Manufacturing
|
2022
|
|
$ |
3,097 |
|
|
|
(145 |
)
|
|
|
14,204 |
|
|
|
110 |
|
|
|
8 |
|
|
2021
|
|
$ |
3,130 |
|
|
|
214 |
|
|
|
12,576 |
|
|
|
98 |
|
|
|
60 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Testing Services
|
2022
|
|
|
4,417 |
|
|
|
(124 |
)
|
|
|
24,030 |
|
|
|
633 |
|
|
|
341 |
|
|
2021
|
|
|
3,504 |
|
|
|
(320 |
)
|
|
|
21,364 |
|
|
|
637 |
|
|
|
344 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distribution
|
2022
|
|
|
3,620 |
|
|
|
576 |
|
|
|
1,601 |
|
|
|
(2 |
) |
|
|
- |
|
|
2021
|
|
|
1,467 |
|
|
|
163 |
|
|
|
983 |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real Estate
|
2022
|
|
|
4 |
|
|
|
(35 |
)
|
|
|
1,730 |
|
|
|
20 |
|
|
|
- |
|
|
2021
|
|
|
11 |
|
|
|
(23 |
)
|
|
|
3,784 |
|
|
|
20 |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate &
|
2022
|
|
|
- |
|
|
|
(402 |
)
|
|
|
238 |
|
|
|
- |
|
|
|
- |
|
Unallocated
|
2021
|
|
|
- |
|
|
|
(99 |
)
|
|
|
418 |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company
|
2022
|
|
$ |
11,138 |
|
|
|
(130 |
) |
|
|
41,803 |
|
|
|
761 |
|
|
|
349 |
|
|
2021
|
|
$ |
8,112 |
|
|
|
(65 |
) |
|
|
39,125 |
|
|
|
755 |
|
|
|
404 |
|
15. OTHER INCOME
Other income consisted of the following:
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
Mar. 31,
|
|
|
Mar. 31,
|
|
|
Mar. 31,
|
|
|
Mar. 31,
|
|
|
|
2022
|
|
|
2021
|
|
|
2022
|
|
|
2021
|
|
|
|
Unaudited
|
|
|
Unaudited
|
|
|
Unaudited
|
|
|
Unaudited
|
|
Interest income
|
|
$ |
13 |
|
|
$ |
26 |
|
|
$ |
51 |
|
|
$ |
96 |
|
Other rental income
|
|
|
30 |
|
|
|
25 |
|
|
|
88 |
|
|
|
70 |
|
Exchange (loss) / Gain
|
|
|
(9 |
) |
|
|
58 |
|
|
|
(13 |
)
|
|
|
(79 |
) |
Bad debt recovery
|
|
|
- |
|
|
|
- |
|
|
|
104 |
|
|
|
10 |
|
Dividend income
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
32 |
|
Government grant
|
|
|
62 |
|
|
|
152 |
|
|
|
160 |
|
|
|
412 |
|
Commission income
|
|
|
- |
|
|
|
- |
|
|
|
200 |
|
|
|
- |
|
Other miscellaneous income
|
|
|
31 |
|
|
|
12 |
|
|
|
79 |
|
|
|
86 |
|
Total
|
|
$ |
127 |
|
|
$ |
273 |
|
|
$ |
669 |
|
|
$ |
627 |
|
The Company received financial assistance in the form of government
grants from the Malaysia and Thailand governments amid the
COVID-19 pandemic. The grants
amounted to $nil and
$61 for the three and nine months ended March 31, 2022, respectively.
The Company received financial assistance in the form of government
grants from the Singapore and Malaysia governments amid the
COVID-19 pandemic. The grants
amounted to $107 and $350 for the three and nine months ended March 31, 2021, respectively.
16. INCOME
TAX
The Company is subject to income taxes in the U.S. and numerous
foreign jurisdictions. Significant judgment is required in
determining the provision for income taxes and income tax assets
and liabilities, including evaluating uncertainties in the
application of accounting principles and complex tax laws. The
statute of limitations, in general, is open for years 2014 to 2020
for tax authorities in those jurisdictions to audit or examine
income tax returns. The Company is under annual review by the tax
authorities of the respective jurisdiction to which the
subsidiaries belong.
The Tax Cuts and Jobs Act (the “Tax Act”) was enacted in fiscal
year 2018, and reduced the U.S.
federal corporate tax rate from 35%
to 21%, eliminated corporate
Alternative Minimum Tax, modified rules for expensing capital
investment, and limited the deduction of interest expense for
certain companies. The Act is a fundamental change to the taxation
of multinational companies, including a shift from a system of
worldwide taxation with some deferral elements to a territorial
system, current taxation of certain foreign income, a minimum tax
on low tax foreign earnings, and new measures to curtail base
erosion and promote U.S. production.
Due to the enactment of the Tax Act, the Company is subject to a
tax on global intangible low-taxed income
(“GILTI”). GILTI is a tax on foreign income in excess of
a deemed return on tangible assets of foreign corporations.
Companies subject to GILTI have the option to account for the GILTI
tax as a period cost if and when incurred, or to recognize deferred
taxes for temporary differences including outside basis differences
expected to reverse as GILTI. The Company has elected to account
for GILTI as a period cost. GILTI expense was $Nil for the period ended March 31, 2022.
The Company's income tax expense was $170 and $503 for the
3 months and 9 months ended March 31, 2022, respectively as compared to
$118 and $125 for the 3 months and
9 months ended March 31, 2021. Our effective tax rate
(“ETR”) from continuing operations was 500.0% and 64.5% for the
quarters ended March 31, 2022 and
March 31, 2021, respectively. The
increase in effective tax rate was due to Singapore operations
incurring higher income tax due to full utilization of tax
allowances coupled with the additional tax arising from under
provision of tax expenses for the financial year ended 2020.
The Company accrues penalties and interest related to unrecognized
tax benefits when necessary as a component of penalties and
interest expenses, respectively. The Company had no unrecognized
tax benefits or related accrued penalties or interest expenses at
March 31, 2022.
In assessing the ability to realize the deferred tax assets,
management considers whether it is more likely than not that some portion or all of the deferred
tax assets will not be realized.
The ultimate realization of deferred tax assets is dependent upon
the generation of future taxable income during the periods in which
those temporary differences become deductible. Management considers
the scheduled reversal of deferred tax liabilities, projected
future taxable income, and tax planning strategies in making this
assessment. Based on these criteria, management believes it is more
likely than not the Company will
not realize the benefits of the
federal, state, and foreign deductible differences. Accordingly, a
full valuation allowance has been established.
17. CONTRACT
BALANCES
The timing of revenue recognition, billings and collections
may result in billed accounts
receivable, unbilled receivables (contract assets), and customer
advances and deposits (contract liabilities). The Company’s payment
terms and conditions vary by contract type, although terms
generally include a requirement of payment of 70% to 90% of total
contract consideration within 30 to
60 days of shipment with the
remainder payable within 30 days of
acceptance. In instances where the timing of revenue recognition
differs from the timing of invoicing, the Company has determined
that its contracts generally do not
include a significant financing component.
The following table is the reconciliation of contract balances.
|
|
Mar. 31,
2022
(Unaudited)
|
|
|
June 30,
2021
|
|
Trade Accounts Receivable
|
|
|
10,585 |
|
|
|
8,293 |
|
Accounts Payable
|
|
|
2,220 |
|
|
|
3,702 |
|
Contract Assets
|
|
|
594 |
|
|
|
337 |
|
Contract Liabilities
|
|
|
1,172 |
|
|
|
673 |
|
Remaining Performance Obligation
As at March 31, 2022, the Company
had $636 of remaining performance obligations, which represents our
obligation to deliver products and services within 2 years
As at June 30, 2021, the Company
had $924 of remaining performance obligations, which represents our
obligation to deliver products and services.
Refer to Note 15 “Business
Segments” of the Notes to Condensed Consolidated Financial
Statements for information related to revenue.
18. (LOSSES) /
EARNINGS PER SHARE
Options to purchase 698,875 shares of Common Stock at exercise
prices ranging from $3.28 to $7.76 per share were outstanding as of
March 31, 2022. 140,500 stock
options were excluded in the computation of diluted EPS for the
three and nine months ended March 31, 2022, because they were
anti-dilutive.
Options to purchase 674,500 shares of Common Stock at exercise
prices ranging from $2.53 to $5.98 per share were outstanding as of
March 31, 2021. 140,000 stock
options were excluded in the computation of diluted EPS for
three and
nine months ended March 31,
2021 because they were anti-dilutive
The following table is a reconciliation of the weighted average
shares used in the computation of basic and diluted EPS for the
period presented herein:
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
Mar. 31,
|
|
|
Mar. 31,
|
|
|
Mar. 31,
|
|
|
Mar. 31, |
|
|
|
2022
|
|
|
2021
|
|
|
2022
|
|
|
2021 |
|
|
|
(Unaudited)
|
|
|
(Unaudited)
|
|
|
(Unaudited)
|
|
|
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss)/income attributable to Trio-Tech International common
shareholders from continuing operations, net of tax
|
|
$ |
(167 |
) |
|
$ |
177 |
|
|
$ |
1,603 |
|
|
$ |
418 |
|
Income / (loss) attributable to Trio-Tech International common
shareholders from discontinued operations, net of tax
|
|
|
- |
|
|
|
1 |
|
|
|
2 |
|
|
|
(13 |
)
|
Net (loss)/income attributable to Trio-Tech International Common
Shareholders
|
|
$ |
(167 |
) |
|
$ |
178 |
|
|
$ |
1,605 |
|
|
$ |
405 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding - basic
|
|
|
3,949 |
|
|
|
3,913 |
|
|
|
3,949 |
|
|
|
3,913 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dilutive effect of stock options
|
|
|
272 |
|
|
|
133 |
|
|
|
191 |
|
|
|
117 |
|
Number of shares used to compute earnings per share - diluted
|
|
|
4,221 |
|
|
|
4,046 |
|
|
|
4,140 |
|
|
|
4,030 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic (losses) / earnings per share from continuing operations
attributable to Trio-Tech International
|
|
$ |
(0.04 |
) |
|
|
0.05 |
|
|
|
0.40 |
|
|
|
0.11 |
|
Basic earnings per share from discontinued operations attributable
to Trio-Tech International
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Basic earnings per share from net income attributable to
Trio-Tech International
|
|
$ |
(0.04 |
)
|
|
$ |
0.05 |
|
|
$ |
0.40 |
|
|
$ |
0.11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share from continuing operations attributable
to Trio-Tech International
|
|
$ |
(0.04 |
) |
|
|
0.04 |
|
|
|
0.38 |
|
|
|
0.10 |
|
Diluted earnings per share from discontinued operations
attributable to Trio-Tech International
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Diluted earnings per share from net income attributable to
Trio-Tech International
|
|
$ |
(0.04 |
) |
|
$ |
0.04 |
|
|
$ |
0.38 |
|
|
$ |
0.10 |
|
19. STOCK
OPTIONS
On September 24, 2007, the
Company’s Board of Directors unanimously adopted the 2007 Employee Stock Option Plan (the
“2007 Employee Plan”) and the
2007 Directors Equity Incentive
Plan (the “2007 Directors Plan”),
each of which was approved by the shareholders on December 3, 2007. Each of those plans was
amended during the term of such plan to increase the number of
shares covered thereby. As of the last amendment thereof, the
2007 Employee Plan covered an
aggregate of 600,000 shares of the Company’s Common Stock and the
2007 Directors Plan covered an
aggregate of 500,000 shares of the Company’s Common Stock. Each of
those plans terminated by its respective terms on September 24, 2017. These two plans were administered by the Board,
which also established the terms of the awards.
On September 14, 2017, the
Company’s Board of Directors unanimously adopted the 2017 Employee Stock Option Plan (the
“2017 Employee Plan”) and the
2017 Directors Equity Incentive
Plan (the “2017 Directors Plan”),
each of which was approved by the shareholders on December 4, 2017. Each of these plans is
administered by the Board of Directors of the Company.
Assumptions
The fair value for the stock options granted to both employees and
directors was estimated using the Black-Scholes option pricing
model with the following weighted average assumptions,
assuming:
|
●
|
An expected life varying from 2.50 to 3.25 years, calculated in
accordance with the guidance provided in SEC Staff bulletin
No. 110 for plain vanilla options using the
simplified method, since our equity shares have been publicly
traded for only a limited period of time and we did not have sufficient historical exercise data
at the grant date of the options;
|
|
●
|
A risk-free interest rate varying from 0.11% to 2.35% (2021: 0.14% to 2.35%);
|
|
●
|
no expected dividend payments and
|
|
●
|
expected volatility of 45.38% to 55.59% (2021: 45.38% to 76.85%).
|
2017 Employee Stock Option
Plan
The Company’s 2017 Employee Plan
permits the grant of stock options to its employees covering up to
an aggregate of 300,000 shares of Common Stock. The Company’s board
of directors approved an amendment to the 2017 Employee Plan in December 2021 to increase the shares covered
thereby from 300,000 shares to an aggregate of 600,000 shares,
which amendment was approved by the Company’s shareholders at the
annual meeting held in December
2021. Under the 2017 Employee
Plan, all options must be granted with an exercise price of
not less than fair value as of the
grant date and the options granted must be exercisable within a
maximum of ten years after the date
of grant, or such lesser period of time as is set forth in the
stock option agreements. The options may be exercisable (a) immediately as of the
effective date of the stock option agreement granting the option,
or (b) in accordance with a schedule related to the date of the
grant of the option, the date of first employment, or such other date as
may be set by the Compensation
Committee. Generally, options granted under the 2017 Employee Plan are exercisable within
five years after the
date of grant and vest over the period as follows: 25% vesting on
the grant date and the remaining balance vesting in equal
installments on the next three
succeeding anniversaries of the grant date. The share-based
compensation will be recognized in terms of the grade method on a
straight-line basis for each separately vesting portion of the
award. Certain option awards provide for accelerated vesting if
there is a change in control (as defined in the 2017 Employee Plan).
During the third quarter of fiscal
year 2022, 40,500 stock options
were granted under the 2017
Employee Plan. There were 41,125 stock options exercised during the
nine-month period ended March 31, 2022. The Company recognized $106
stock-based compensation expenses during the nine months ended March 31, 2022.
During the third quarter of fiscal
year 2021, the Company granted
options to purchase 71,000 shares of its Common Stock to employees
pursuant to the 2017 Employee Plan.
There were no stock options granted under the 2017 Employee Plan exercised during the
nine-month period ended March 31, 2021. The Company recognized $45 in
stock-based compensation expenses during the nine months ended March 31, 2021.
As of March 31, 2022, there were
vested stock options granted under the 2017 Employee Plan covering a total of
170,500 shares of Common Stock. The weighted-average exercise price
was $4.81 and the weighted average remaining contractual term was
2.24 years.
As of March 31, 2021, there were
vested stock options granted under the 2017 Employee Plan covering a total of
149,750 shares of Common Stock. The weighted-average exercise price
was $4.46 and the weighted average remaining contractual term was
2.99 years.
A summary of option activities under the 2017 Employee Plan during the nine months period ended March 31, 2022, is presented as follows:
|
|
Options
|
|
|
Weighted Average
Exercise
Price
|
|
|
Weighted Average Remaining
Contractual Term
(Years)
|
|
|
Aggregate
Intrinsic
Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at July 1, 2021
|
|
|
267,000 |
|
|
$ |
4.21 |
|
|
|
3.22 |
|
|
$ |
290 |
|
Granted
|
|
|
40,500 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Exercised
|
|
|
(41,125 |
)
|
|
|
2.86 |
|
|
|
- |
|
|
|
- |
|
Forfeited or expired
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Outstanding at March 31, 2022
|
|
|
266,375 |
|
|
$ |
4.96 |
|
|
|
2.80 |
|
|
$ |
621 |
|
Exercisable at March 31, 2022
|
|
|
170,500 |
|
|
$ |
4.81 |
|
|
|
2.24 |
|
|
$ |
415 |
|
A summary of the status of the Company’s non-vested employee stock
options during the nine months
ended March 31, 2022, is presented
below:
|
|
Options
|
|
|
Weighted
Average
Grant-Date
Fair Value
|
|
|
|
|
|
|
|
|
|
|
Non-vested at July 1, 2021
|
|
|
102,250 |
|
|
$ |
2.29 |
|
Granted
|
|
|
40,500 |
|
|
|
- |
|
Vested
|
|
|
(46,875 |
)
|
|
|
- |
|
Forfeited
|
|
|
- |
|
|
|
- |
|
Non-vested at March 31, 2022
|
|
|
95,875 |
|
|
$ |
5.23 |
|
A summary of option activities under the 2017 Employee Plan during the nine months period ended March 31, 2021, is presented as follows:
|
|
Options
|
|
|
Weighted Average
Exercise
Price
|
|
|
Weighted Average Remaining
Contractual Term
(Years)
|
|
|
Aggregate
Intrinsic
Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at July 1, 2020
|
|
|
196,000 |
|
|
$ |
3.92 |
|
|
|
3.72 |
|
|
$ |
36.00 |
|
Granted
|
|
|
71,000 |
|
|
|
5.03 |
|
|
|
- |
|
|
|
- |
|
Exercised
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Forfeited or expired
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Outstanding at March 31, 2021
|
|
|
267,000 |
|
|
$ |
4.21 |
|
|
|
3.47 |
|
|
$ |
210.40 |
|
Exercisable at March 31, 2021
|
|
|
149,750 |
|
|
$ |
4.46 |
|
|
|
2.99 |
|
|
$ |
106.07 |
|
A summary of the status of the Company’s non-vested employee stock
options during the nine months
ended March 31, 2021, is presented
below:
|
|
Options
|
|
|
Weighted
Average
Grant-Date
Fair Value
|
|
|
|
|
|
|
|
|
|
|
Non-vested at July 1, 2020
|
|
|
98,000 |
|
|
$ |
3.39 |
|
Granted
|
|
|
71,000 |
|
|
|
- |
|
Vested
|
|
|
(51,750 |
)
|
|
|
- |
|
Forfeited
|
|
|
- |
|
|
|
- |
|
Non-vested at March 31, 2021
|
|
|
117,250 |
|
|
$ |
3.90 |
|
2007 Employee Stock Option
Plan
The 2007 Employee Plan terminated
by its terms on September 24, 2017
and no further options may be granted thereunder. However, the
options outstanding thereunder continue to remain outstanding and
in effect in accordance with their terms. The 2007 Employee Plan permitted the issuance of
options to employees.
As the 2007 Plan has terminated,
the Company did not grant any
options pursuant to the 2007
Employee Plan during the nine
months ended March 31, 2022, and
March 31, 2021 respectively.
There were 37,500 options exercised during the nine months ended March 31, 2022 and none exercised in March 31, 2021. The Company did not recognize any
stock-based compensation expenses during the nine months ended March 31, 2022, and March 31, 2021.
As of March 31, 2022, there were
no vested stock
options granted under the 2007
Employee Plan.
As of March 31, 2021, there were
vested stock options granted under the 2007 Employee Plan covering a total of 37,500
shares of Common Stock. The weighted-average exercise price was
$4.14 and the weighted average remaining contractual term was 0.99
years.
A summary of option activities under the 2007 Employee Plan during the nine months ended March 31, 2022, is presented as follows:
|
|
Options
|
|
|
Weighted Average
Exercise
Price
|
|
|
Weighted Average Remaining
Contractual
Term (Years)
|
|
|
Aggregate
Intrinsic
Value
|
|
Outstanding at July 1, 2021
|
|
|
37,500 |
|
|
$ |
4.14 |
|
|
|
0.75 |
|
|
$ |
34 |
|
Granted
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Exercised
|
|
|
(37,500 |
) |
|
|
4.14 |
|
|
|
- |
|
|
|
- |
|
Forfeited or expired
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Outstanding at March 31, 2022
|
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
|
$ |
- |
|
There were no non-vested employee stock options during the
nine months ended March 31, 2022.
A summary of option activities under the 2007 Employee Plan during the nine months ended March 31, 2021, is presented as follows:
|
|
Options
|
|
|
Weighted Average
Exercise
Price
|
|
|
Weighted Average Remaining
Contractual
Term (Years)
|
|
|
Aggregate
Intrinsic
Value
|
|
Outstanding at July 1, 2020
|
|
|
77,500 |
|
|
$ |
3.69 |
|
|
|
1.22 |
|
|
$ |
- |
|
Granted
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Exercised
|
|
|
(40,000 |
) |
|
|
3.26 |
|
|
|
- |
|
|
|
- |
|
Forfeited or expired
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Outstanding at March 31, 2021
|
|
|
37,500 |
|
|
$ |
4.14 |
|
|
|
0.99 |
|
|
$ |
13.13 |
|
Exercisable at March 31, 2021
|
|
|
37,500 |
|
|
$ |
4.14 |
|
|
|
0.99 |
|
|
$ |
13.13 |
|
There were no non-vested employee stock options during the
nine months ended March 31, 2021.
2017 Directors Equity Incentive
Plan
The 2017 Directors Plan initially
covered an aggregate of 300,000 shares of the Company’s common
stock. The Company’s board of directors approved an amendment to
the 2017 Directors Plan in
September 2020 to increase the
shares covered thereby from 300,000 shares to an aggregate of
600,000 shares, which amendment was approved by the Company’s
shareholders at the annual meeting held in December 2020. The 2017 Directors Plan permits the grant of
options to its directors in the form of nonqualified options and
restricted stock. The exercise price of the nonqualified options is
required to be 100% of the fair
value of the underlying shares on the grant date. The options have
five-year contractual
terms and are exercisable immediately as of the grant date.
During the third quarters of fiscal
year 2022, the Company granted
options to purchase 100,000 shares of its Common Stock pursuant to
the 2017 Directors Plan. There were
no stock options exercised during the nine months ended March 31, 2022. The Company recognize $353
stock-based compensation expenses during the nine months ended March 31, 2022.
During the third quarter of fiscal
year 2021, the Company granted
options to purchase 80,000 shares of its Common Stock pursuant to
the 2017 Directors Plan. There were
no stock options exercised during the nine months ended March 31, 2021. The Company recognized $99
stock-based compensation expenses during the nine months ended March 31, 2021.
As all the stock options granted under the 2017 Directors Plan vest immediately on the
date of grant, there were no unvested stock options granted under
the 2017 Directors Plan as of
March 31, 2022, or March 31, 2021.
As of March 31, 2022, there were
vested stock options granted under the 2017 Directors Plan covering a total of
420,000 shares of Common Stock. The weighted-average exercise price
was $5.10 and the weighted average remaining contractual term was
3.10 years.
As of March 31, 2021, there were
vested stock options granted under the 2017 Directors Plan covering a total of
320,000 shares of Common Stock. The weighted-average exercise price
was $4.27 and the weighted average remaining contractual term was
3.47 years.
A summary of option activities under the 2017 Directors Plan during the three months ended March 31, 2022, is presented as
follows:
|
|
Options
|
|
|
Weighted Average
Exercise
Price
|
|
|
Weighted Average Remaining
Contractual Term
(Years)
|
|
|
Aggregate
Intrinsic
Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at July 1, 2021
|
|
|
320,000 |
|
|
$ |
4.27 |
|
|
|
3.22 |
|
|
$ |
340 |
|
Granted
|
|
|
100,000 |
|
|
|
7.76 |
|
|
|
- |
|
|
|
- |
|
Exercised
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Forfeited or expired
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Outstanding at March 31, 2022
|
|
|
420,000 |
|
|
|
5.10 |
|
|
|
0.60 |
|
|
|
942 |
|
Exercisable at March 31, 2022
|
|
|
420,000 |
|
|
|
5.10 |
|
|
|
3.07 |
|
|
|
942 |
|
- 28-
A summary of option activities under the 2017 Directors Plan during the nine months ended March 31, 2021, is presented as
follows:
|
|
Options
|
|
|
Weighted Average
Exercise
Price
|
|
|
Weighted Average Remaining
Contractual Term
(Years)
|
|
|
Aggregate
Intrinsic
Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at July 1, 2020
|
|
|
240,000 |
|
|
$ |
3.93 |
|
|
|
3.75 |
|
|
$ |
48.00 |
|
Granted
|
|
|
80,000 |
|
|
|
5.27 |
|
|
|
4.89 |
|
|
|
- |
|
Exercised
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Forfeited or expired
|
|
|